{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "10cdb37a",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "data = pd.read_csv('compounds_with_safety.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "25187ee6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(6373, 55)"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "dfe380b7",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['compound_name', 'clinical_phase', 'disease_area', 'indication',\n",
       "       'mechanism_of_action', 'cf_max_score', 'cf_avg_score', 'cf_top_pose',\n",
       "       'docking_max_score', 'docking_avg_score', 'docking_top_pose',\n",
       "       'safety_Aurora kinase A', 'safety_Bile Salt Export Pump model 2',\n",
       "       'safety_Caspase 3', 'safety_Cathepsin L1', 'safety_hERG_pIC50',\n",
       "       'safety_KCNA5', 'safety_Muscarinic acetylcholine receptor M1',\n",
       "       'safety_Muscarinic acetylcholine receptor M3', 'hERG_pIC50', 'KCNA5',\n",
       "       'pk_Human microsomal clearance model 2', 'chem_a_acc', 'chem_a_don',\n",
       "       'chem_chi0', 'chem_chi1', 'chem_chi0_c', 'chem_chi1_c', 'chem_kier1',\n",
       "       'chem_lip_acc', 'chem_npr1', 'chem_peoe_pcplus', 'chem_peoe_vsaplus0',\n",
       "       'chem_peoe_vsaplus2', 'chem_peoe_vsaplus4', 'chem_peoe_vsaplus6',\n",
       "       'chem_peoe_vsaminus1', 'chem_peoe_vsaminus3', 'chem_peoe_vsaminus5',\n",
       "       'chem_pmi', 'chem_pmi2', 'chem_pmix', 'chem_pmiz', 'chem_slogp',\n",
       "       'chem_slogp_vsa1', 'chem_slogp_vsa3', 'chem_slogp_vsa5',\n",
       "       'chem_slogp_vsa7', 'chem_slogp_vsa9', 'chem_smr_vsa0', 'chem_smr_vsa2',\n",
       "       'chem_smr_vsa4', 'chem_smr_vsa6', 'chem_tpsa', 'cv_safety_score'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "2a6c355f",
   "metadata": {},
   "outputs": [],
   "source": [
    "data_herg = data.sort_values(by = 'hERG_pIC50', ascending = True)[:200]\n",
    "data_aurora = data.sort_values(by = 'safety_Aurora kinase A', ascending = True)[:200]\n",
    "data_kcn = data.sort_values(by = 'safety_KCNA5', ascending = False)[:200]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "4da442c5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# ranked by docking\n",
    "data_herg = data_herg.sort_values(by = 'docking_avg_score', ascending = True)\n",
    "data_aurora = data_aurora.sort_values(by = 'docking_avg_score', ascending = True)\n",
    "data_kcn = data_kcn.sort_values(by = 'docking_avg_score', ascending = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "024d9798",
   "metadata": {},
   "outputs": [],
   "source": [
    "# choose top 100 from three\n",
    "\n",
    "combined = pd.concat([data_herg, data_aurora, data_kcn], ignore_index=True)\n",
    "combined = combined.drop_duplicates()\n",
    "combined = combined[:100]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "ebca3d54",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>compound_name</th>\n",
       "      <th>clinical_phase</th>\n",
       "      <th>disease_area</th>\n",
       "      <th>indication</th>\n",
       "      <th>mechanism_of_action</th>\n",
       "      <th>cf_max_score</th>\n",
       "      <th>cf_avg_score</th>\n",
       "      <th>cf_top_pose</th>\n",
       "      <th>docking_max_score</th>\n",
       "      <th>docking_avg_score</th>\n",
       "      <th>...</th>\n",
       "      <th>chem_slogp_vsa3</th>\n",
       "      <th>chem_slogp_vsa5</th>\n",
       "      <th>chem_slogp_vsa7</th>\n",
       "      <th>chem_slogp_vsa9</th>\n",
       "      <th>chem_smr_vsa0</th>\n",
       "      <th>chem_smr_vsa2</th>\n",
       "      <th>chem_smr_vsa4</th>\n",
       "      <th>chem_smr_vsa6</th>\n",
       "      <th>chem_tpsa</th>\n",
       "      <th>cv_safety_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>dicoumarol</td>\n",
       "      <td>Launched</td>\n",
       "      <td>hematology</td>\n",
       "      <td>deep vein thrombosis (DVT)</td>\n",
       "      <td>NADPH inhibitor</td>\n",
       "      <td>6.78</td>\n",
       "      <td>6.207</td>\n",
       "      <td>5.93</td>\n",
       "      <td>-7.0</td>\n",
       "      <td>-7.16</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>6.37</td>\n",
       "      <td>141.15</td>\n",
       "      <td>10.49</td>\n",
       "      <td>133.09</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>15.49</td>\n",
       "      <td>98.72</td>\n",
       "      <td>4.360</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>deferasirox</td>\n",
       "      <td>Launched</td>\n",
       "      <td>hematology</td>\n",
       "      <td>iron overload</td>\n",
       "      <td>chelating agent</td>\n",
       "      <td>6.80</td>\n",
       "      <td>5.801</td>\n",
       "      <td>5.95</td>\n",
       "      <td>-6.7</td>\n",
       "      <td>-6.84</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>225.50</td>\n",
       "      <td>10.49</td>\n",
       "      <td>66.55</td>\n",
       "      <td>0.00</td>\n",
       "      <td>13.78</td>\n",
       "      <td>1.46</td>\n",
       "      <td>111.30</td>\n",
       "      <td>5.095</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>omtriptolide</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ERK1 and ERK2 phosphorylation inhibitor</td>\n",
       "      <td>8.05</td>\n",
       "      <td>6.352</td>\n",
       "      <td>6.62</td>\n",
       "      <td>-6.4</td>\n",
       "      <td>-6.66</td>\n",
       "      <td>...</td>\n",
       "      <td>20.93</td>\n",
       "      <td>6.37</td>\n",
       "      <td>0.00</td>\n",
       "      <td>99.98</td>\n",
       "      <td>169.27</td>\n",
       "      <td>8.82</td>\n",
       "      <td>0.00</td>\n",
       "      <td>37.88</td>\n",
       "      <td>130.32</td>\n",
       "      <td>4.905</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>dehydrocholate</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7.68</td>\n",
       "      <td>5.334</td>\n",
       "      <td>4.04</td>\n",
       "      <td>-6.2</td>\n",
       "      <td>-6.54</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>99.98</td>\n",
       "      <td>138.13</td>\n",
       "      <td>26.46</td>\n",
       "      <td>0.00</td>\n",
       "      <td>18.53</td>\n",
       "      <td>91.34</td>\n",
       "      <td>4.865</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>dehydrocholate-acid</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7.68</td>\n",
       "      <td>5.334</td>\n",
       "      <td>4.04</td>\n",
       "      <td>-6.2</td>\n",
       "      <td>-6.54</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>99.98</td>\n",
       "      <td>138.13</td>\n",
       "      <td>26.46</td>\n",
       "      <td>0.00</td>\n",
       "      <td>18.53</td>\n",
       "      <td>91.34</td>\n",
       "      <td>4.845</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>95</th>\n",
       "      <td>nadifloxacin</td>\n",
       "      <td>Launched</td>\n",
       "      <td>dermatology</td>\n",
       "      <td>acne vulgaris (AV)</td>\n",
       "      <td>bacterial DNA gyrase inhibitor</td>\n",
       "      <td>6.50</td>\n",
       "      <td>5.301</td>\n",
       "      <td>5.58</td>\n",
       "      <td>-4.9</td>\n",
       "      <td>-5.04</td>\n",
       "      <td>...</td>\n",
       "      <td>36.88</td>\n",
       "      <td>22.05</td>\n",
       "      <td>34.86</td>\n",
       "      <td>53.80</td>\n",
       "      <td>90.41</td>\n",
       "      <td>15.37</td>\n",
       "      <td>5.51</td>\n",
       "      <td>44.03</td>\n",
       "      <td>83.91</td>\n",
       "      <td>5.045</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>96</th>\n",
       "      <td>difloxacin</td>\n",
       "      <td>Launched</td>\n",
       "      <td>dermatology</td>\n",
       "      <td>acne vulgaris (AV)</td>\n",
       "      <td>bacterial DNA gyrase inhibitor</td>\n",
       "      <td>6.50</td>\n",
       "      <td>5.301</td>\n",
       "      <td>5.58</td>\n",
       "      <td>-4.9</td>\n",
       "      <td>-5.04</td>\n",
       "      <td>...</td>\n",
       "      <td>36.88</td>\n",
       "      <td>22.05</td>\n",
       "      <td>34.86</td>\n",
       "      <td>53.80</td>\n",
       "      <td>90.41</td>\n",
       "      <td>15.37</td>\n",
       "      <td>5.51</td>\n",
       "      <td>44.03</td>\n",
       "      <td>83.91</td>\n",
       "      <td>5.045</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>97</th>\n",
       "      <td>tavilermide</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>tyrosine kinase partial agonist</td>\n",
       "      <td>5.83</td>\n",
       "      <td>5.178</td>\n",
       "      <td>4.88</td>\n",
       "      <td>-4.8</td>\n",
       "      <td>-5.03</td>\n",
       "      <td>...</td>\n",
       "      <td>108.74</td>\n",
       "      <td>0.00</td>\n",
       "      <td>52.93</td>\n",
       "      <td>8.00</td>\n",
       "      <td>235.63</td>\n",
       "      <td>155.88</td>\n",
       "      <td>2.76</td>\n",
       "      <td>81.77</td>\n",
       "      <td>279.35</td>\n",
       "      <td>4.520</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>98</th>\n",
       "      <td>ramipril</td>\n",
       "      <td>Launched</td>\n",
       "      <td>cardiology</td>\n",
       "      <td>hypertension</td>\n",
       "      <td>angiotensin converting enzyme inhibitor</td>\n",
       "      <td>5.93</td>\n",
       "      <td>4.950</td>\n",
       "      <td>3.92</td>\n",
       "      <td>-4.9</td>\n",
       "      <td>-5.03</td>\n",
       "      <td>...</td>\n",
       "      <td>20.93</td>\n",
       "      <td>18.87</td>\n",
       "      <td>88.22</td>\n",
       "      <td>66.65</td>\n",
       "      <td>125.27</td>\n",
       "      <td>22.42</td>\n",
       "      <td>0.00</td>\n",
       "      <td>35.39</td>\n",
       "      <td>98.77</td>\n",
       "      <td>5.105</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>99</th>\n",
       "      <td>apramycin</td>\n",
       "      <td>Launched</td>\n",
       "      <td>infectious disease</td>\n",
       "      <td>gram-negative bacterial infections</td>\n",
       "      <td>bacterial 30S ribosomal subunit inhibitor</td>\n",
       "      <td>5.57</td>\n",
       "      <td>4.651</td>\n",
       "      <td>5.31</td>\n",
       "      <td>-4.9</td>\n",
       "      <td>-5.02</td>\n",
       "      <td>...</td>\n",
       "      <td>20.93</td>\n",
       "      <td>32.90</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>55.00</td>\n",
       "      <td>131.59</td>\n",
       "      <td>0.00</td>\n",
       "      <td>20.93</td>\n",
       "      <td>294.70</td>\n",
       "      <td>4.660</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>100 rows × 55 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          compound_name clinical_phase        disease_area  \\\n",
       "0            dicoumarol       Launched          hematology   \n",
       "1           deferasirox       Launched          hematology   \n",
       "2          omtriptolide    Preclinical                 NaN   \n",
       "3        dehydrocholate    Preclinical                 NaN   \n",
       "4   dehydrocholate-acid    Preclinical                 NaN   \n",
       "..                  ...            ...                 ...   \n",
       "95         nadifloxacin       Launched         dermatology   \n",
       "96           difloxacin       Launched         dermatology   \n",
       "97          tavilermide        Phase 3                 NaN   \n",
       "98             ramipril       Launched          cardiology   \n",
       "99            apramycin       Launched  infectious disease   \n",
       "\n",
       "                            indication  \\\n",
       "0           deep vein thrombosis (DVT)   \n",
       "1                        iron overload   \n",
       "2                                  NaN   \n",
       "3                                  NaN   \n",
       "4                                  NaN   \n",
       "..                                 ...   \n",
       "95                  acne vulgaris (AV)   \n",
       "96                  acne vulgaris (AV)   \n",
       "97                                 NaN   \n",
       "98                        hypertension   \n",
       "99  gram-negative bacterial infections   \n",
       "\n",
       "                          mechanism_of_action  cf_max_score  cf_avg_score  \\\n",
       "0                             NADPH inhibitor          6.78         6.207   \n",
       "1                             chelating agent          6.80         5.801   \n",
       "2     ERK1 and ERK2 phosphorylation inhibitor          8.05         6.352   \n",
       "3                                         NaN          7.68         5.334   \n",
       "4                                         NaN          7.68         5.334   \n",
       "..                                        ...           ...           ...   \n",
       "95             bacterial DNA gyrase inhibitor          6.50         5.301   \n",
       "96             bacterial DNA gyrase inhibitor          6.50         5.301   \n",
       "97            tyrosine kinase partial agonist          5.83         5.178   \n",
       "98    angiotensin converting enzyme inhibitor          5.93         4.950   \n",
       "99  bacterial 30S ribosomal subunit inhibitor          5.57         4.651   \n",
       "\n",
       "    cf_top_pose  docking_max_score  docking_avg_score  ...  chem_slogp_vsa3  \\\n",
       "0          5.93               -7.0              -7.16  ...             0.00   \n",
       "1          5.95               -6.7              -6.84  ...             0.00   \n",
       "2          6.62               -6.4              -6.66  ...            20.93   \n",
       "3          4.04               -6.2              -6.54  ...             0.00   \n",
       "4          4.04               -6.2              -6.54  ...             0.00   \n",
       "..          ...                ...                ...  ...              ...   \n",
       "95         5.58               -4.9              -5.04  ...            36.88   \n",
       "96         5.58               -4.9              -5.04  ...            36.88   \n",
       "97         4.88               -4.8              -5.03  ...           108.74   \n",
       "98         3.92               -4.9              -5.03  ...            20.93   \n",
       "99         5.31               -4.9              -5.02  ...            20.93   \n",
       "\n",
       "    chem_slogp_vsa5  chem_slogp_vsa7  chem_slogp_vsa9  chem_smr_vsa0  \\\n",
       "0              6.37           141.15            10.49         133.09   \n",
       "1              0.00           225.50            10.49          66.55   \n",
       "2              6.37             0.00            99.98         169.27   \n",
       "3              0.00             0.00            99.98         138.13   \n",
       "4              0.00             0.00            99.98         138.13   \n",
       "..              ...              ...              ...            ...   \n",
       "95            22.05            34.86            53.80          90.41   \n",
       "96            22.05            34.86            53.80          90.41   \n",
       "97             0.00            52.93             8.00         235.63   \n",
       "98            18.87            88.22            66.65         125.27   \n",
       "99            32.90             0.00             0.00          55.00   \n",
       "\n",
       "    chem_smr_vsa2  chem_smr_vsa4  chem_smr_vsa6  chem_tpsa  cv_safety_score  \n",
       "0            0.00           0.00          15.49      98.72            4.360  \n",
       "1            0.00          13.78           1.46     111.30            5.095  \n",
       "2            8.82           0.00          37.88     130.32            4.905  \n",
       "3           26.46           0.00          18.53      91.34            4.865  \n",
       "4           26.46           0.00          18.53      91.34            4.845  \n",
       "..            ...            ...            ...        ...              ...  \n",
       "95          15.37           5.51          44.03      83.91            5.045  \n",
       "96          15.37           5.51          44.03      83.91            5.045  \n",
       "97         155.88           2.76          81.77     279.35            4.520  \n",
       "98          22.42           0.00          35.39      98.77            5.105  \n",
       "99         131.59           0.00          20.93     294.70            4.660  \n",
       "\n",
       "[100 rows x 55 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "combined"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "ea6e9a33",
   "metadata": {},
   "outputs": [],
   "source": [
    "compound_list = [\n",
    "    \"andarine\", \"AZD2461\", \"BMS-906024\", \"candesartan\", \"CPI-0610\", \"cycloheximide\",\n",
    "    \"dienogest\", \"epinastine\", \"evodiamine\", \"hypericin\", \"I-BRD9\", \"ilaprazole\",\n",
    "    \"indiplon\", \"INT-767\", \"ITX3\", \"K-strophanthidin\", \"L-701324\", \"LY2183240\",\n",
    "    \"MK-1064\", \"monensin\", \"narasin\", \"navarixin\", \"obeticholic-acid\",\n",
    "    \"olmesartan-medoxomil\", \"palmatine-chloride\", \"perfluorodecalin\",\n",
    "    \"PF-04217903\", \"PF-477736\", \"PIK-293\", \"resmetirom\", \"RU-28318\",\n",
    "    \"sanguinarium-chloride\", \"SCH-58261\", \"SP-100030\", \"SPP86\", \"sulfinpyrazone\",\n",
    "    \"sulindac\", \"TAK-063\", \"TC-S-7009\", \"TEPP-46\", \"tivantinib\"\n",
    "]\n",
    "\n",
    "# Filter for found and not found\n",
    "found_df = combined[combined['compound_name'].isin(compound_list)].copy()\n",
    "found_names = set(found_df['compound_name'])\n",
    "not_found_names = [name for name in compound_list if name not in found_names]\n",
    "\n",
    "# Create not found DataFrame\n",
    "not_found_df = pd.DataFrame(not_found_names, columns=['compound_name'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "1fa51978",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>compound_name</th>\n",
       "      <th>clinical_phase</th>\n",
       "      <th>disease_area</th>\n",
       "      <th>indication</th>\n",
       "      <th>mechanism_of_action</th>\n",
       "      <th>cf_max_score</th>\n",
       "      <th>cf_avg_score</th>\n",
       "      <th>cf_top_pose</th>\n",
       "      <th>docking_max_score</th>\n",
       "      <th>docking_avg_score</th>\n",
       "      <th>...</th>\n",
       "      <th>chem_slogp_vsa3</th>\n",
       "      <th>chem_slogp_vsa5</th>\n",
       "      <th>chem_slogp_vsa7</th>\n",
       "      <th>chem_slogp_vsa9</th>\n",
       "      <th>chem_smr_vsa0</th>\n",
       "      <th>chem_smr_vsa2</th>\n",
       "      <th>chem_smr_vsa4</th>\n",
       "      <th>chem_smr_vsa6</th>\n",
       "      <th>chem_tpsa</th>\n",
       "      <th>cv_safety_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>candesartan</td>\n",
       "      <td>Launched</td>\n",
       "      <td>cardiology</td>\n",
       "      <td>congestive heart failure</td>\n",
       "      <td>angiotensin receptor antagonist</td>\n",
       "      <td>7.8</td>\n",
       "      <td>5.861</td>\n",
       "      <td>5.02</td>\n",
       "      <td>-5.9</td>\n",
       "      <td>-6.14</td>\n",
       "      <td>...</td>\n",
       "      <td>20.93</td>\n",
       "      <td>0.0</td>\n",
       "      <td>210.25</td>\n",
       "      <td>56.15</td>\n",
       "      <td>66.55</td>\n",
       "      <td>0.0</td>\n",
       "      <td>16.17</td>\n",
       "      <td>22.39</td>\n",
       "      <td>105.85</td>\n",
       "      <td>5.085</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1 rows × 55 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   compound_name clinical_phase disease_area                indication  \\\n",
       "21   candesartan       Launched   cardiology  congestive heart failure   \n",
       "\n",
       "                mechanism_of_action  cf_max_score  cf_avg_score  cf_top_pose  \\\n",
       "21  angiotensin receptor antagonist           7.8         5.861         5.02   \n",
       "\n",
       "    docking_max_score  docking_avg_score  ...  chem_slogp_vsa3  \\\n",
       "21               -5.9              -6.14  ...            20.93   \n",
       "\n",
       "    chem_slogp_vsa5  chem_slogp_vsa7  chem_slogp_vsa9  chem_smr_vsa0  \\\n",
       "21              0.0           210.25            56.15          66.55   \n",
       "\n",
       "    chem_smr_vsa2  chem_smr_vsa4  chem_smr_vsa6  chem_tpsa  cv_safety_score  \n",
       "21            0.0          16.17          22.39     105.85            5.085  \n",
       "\n",
       "[1 rows x 55 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "found_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "6dd59be9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>compound_name</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>andarine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>AZD2461</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>BMS-906024</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>CPI-0610</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>cycloheximide</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>dienogest</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>epinastine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>evodiamine</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>hypericin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>I-BRD9</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>ilaprazole</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>indiplon</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>INT-767</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>ITX3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>K-strophanthidin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>L-701324</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>LY2183240</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>MK-1064</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>monensin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>narasin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>navarixin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>obeticholic-acid</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>olmesartan-medoxomil</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>palmatine-chloride</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>perfluorodecalin</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>PF-04217903</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>PF-477736</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>PIK-293</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>resmetirom</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>RU-28318</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>sanguinarium-chloride</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>SCH-58261</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>SP-100030</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>SPP86</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>sulfinpyrazone</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>sulindac</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>TAK-063</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>TC-S-7009</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>TEPP-46</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>tivantinib</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "            compound_name\n",
       "0                andarine\n",
       "1                 AZD2461\n",
       "2              BMS-906024\n",
       "3                CPI-0610\n",
       "4           cycloheximide\n",
       "5               dienogest\n",
       "6              epinastine\n",
       "7              evodiamine\n",
       "8               hypericin\n",
       "9                  I-BRD9\n",
       "10             ilaprazole\n",
       "11               indiplon\n",
       "12                INT-767\n",
       "13                   ITX3\n",
       "14       K-strophanthidin\n",
       "15               L-701324\n",
       "16              LY2183240\n",
       "17                MK-1064\n",
       "18               monensin\n",
       "19                narasin\n",
       "20              navarixin\n",
       "21       obeticholic-acid\n",
       "22   olmesartan-medoxomil\n",
       "23     palmatine-chloride\n",
       "24       perfluorodecalin\n",
       "25            PF-04217903\n",
       "26              PF-477736\n",
       "27                PIK-293\n",
       "28             resmetirom\n",
       "29               RU-28318\n",
       "30  sanguinarium-chloride\n",
       "31              SCH-58261\n",
       "32              SP-100030\n",
       "33                  SPP86\n",
       "34         sulfinpyrazone\n",
       "35               sulindac\n",
       "36                TAK-063\n",
       "37              TC-S-7009\n",
       "38                TEPP-46\n",
       "39             tivantinib"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "not_found_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "ac50c6db",
   "metadata": {},
   "outputs": [],
   "source": [
    "found_df = data[data['compound_name'].isin(compound_list)].copy()\n",
    "found_names = set(found_df['compound_name'])\n",
    "not_found_names = [name for name in compound_list if name not in found_names]\n",
    "\n",
    "# Create not found DataFrame\n",
    "not_found_df = pd.DataFrame(not_found_names, columns=['compound_name'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "26b2a457",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>compound_name</th>\n",
       "      <th>clinical_phase</th>\n",
       "      <th>disease_area</th>\n",
       "      <th>indication</th>\n",
       "      <th>mechanism_of_action</th>\n",
       "      <th>cf_max_score</th>\n",
       "      <th>cf_avg_score</th>\n",
       "      <th>cf_top_pose</th>\n",
       "      <th>docking_max_score</th>\n",
       "      <th>docking_avg_score</th>\n",
       "      <th>...</th>\n",
       "      <th>chem_slogp_vsa3</th>\n",
       "      <th>chem_slogp_vsa5</th>\n",
       "      <th>chem_slogp_vsa7</th>\n",
       "      <th>chem_slogp_vsa9</th>\n",
       "      <th>chem_smr_vsa0</th>\n",
       "      <th>chem_smr_vsa2</th>\n",
       "      <th>chem_smr_vsa4</th>\n",
       "      <th>chem_smr_vsa6</th>\n",
       "      <th>chem_tpsa</th>\n",
       "      <th>cv_safety_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>586</th>\n",
       "      <td>indiplon</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>benzodiazepine receptor agonist</td>\n",
       "      <td>7.91</td>\n",
       "      <td>7.006</td>\n",
       "      <td>7.16</td>\n",
       "      <td>-5.9</td>\n",
       "      <td>-6.07</td>\n",
       "      <td>...</td>\n",
       "      <td>2.76</td>\n",
       "      <td>49.68</td>\n",
       "      <td>156.53</td>\n",
       "      <td>69.69</td>\n",
       "      <td>47.72</td>\n",
       "      <td>5.88</td>\n",
       "      <td>5.08</td>\n",
       "      <td>10.95</td>\n",
       "      <td>67.56</td>\n",
       "      <td>5.905</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>769</th>\n",
       "      <td>sulfinpyrazone</td>\n",
       "      <td>Launched</td>\n",
       "      <td>rheumatology</td>\n",
       "      <td>gout</td>\n",
       "      <td>uricosuric blocker</td>\n",
       "      <td>7.90</td>\n",
       "      <td>6.700</td>\n",
       "      <td>7.31</td>\n",
       "      <td>-6.3</td>\n",
       "      <td>-6.45</td>\n",
       "      <td>...</td>\n",
       "      <td>17.23</td>\n",
       "      <td>1.55</td>\n",
       "      <td>264.65</td>\n",
       "      <td>5.51</td>\n",
       "      <td>71.81</td>\n",
       "      <td>11.97</td>\n",
       "      <td>5.51</td>\n",
       "      <td>27.75</td>\n",
       "      <td>76.90</td>\n",
       "      <td>5.355</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1116</th>\n",
       "      <td>ilaprazole</td>\n",
       "      <td>Launched</td>\n",
       "      <td>gastroenterology</td>\n",
       "      <td>gastroesophageal reflux disease (GERD)</td>\n",
       "      <td>proton pump inhibitor</td>\n",
       "      <td>8.09</td>\n",
       "      <td>6.908</td>\n",
       "      <td>8.09</td>\n",
       "      <td>-6.0</td>\n",
       "      <td>-6.21</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>36.08</td>\n",
       "      <td>164.55</td>\n",
       "      <td>55.80</td>\n",
       "      <td>24.09</td>\n",
       "      <td>17.48</td>\n",
       "      <td>7.05</td>\n",
       "      <td>0.00</td>\n",
       "      <td>92.01</td>\n",
       "      <td>5.515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1204</th>\n",
       "      <td>SPP86</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>receptor tyrosine protein kinase inhibitor</td>\n",
       "      <td>8.32</td>\n",
       "      <td>6.542</td>\n",
       "      <td>7.30</td>\n",
       "      <td>-5.8</td>\n",
       "      <td>-6.09</td>\n",
       "      <td>...</td>\n",
       "      <td>34.06</td>\n",
       "      <td>0.00</td>\n",
       "      <td>109.29</td>\n",
       "      <td>68.98</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>6.62</td>\n",
       "      <td>0.00</td>\n",
       "      <td>69.62</td>\n",
       "      <td>5.760</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1216</th>\n",
       "      <td>LY2183240</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FAAH inhibitor  FAAH reuptake inhibitor</td>\n",
       "      <td>8.66</td>\n",
       "      <td>7.416</td>\n",
       "      <td>5.36</td>\n",
       "      <td>-6.7</td>\n",
       "      <td>-6.90</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>84.66</td>\n",
       "      <td>165.16</td>\n",
       "      <td>23.86</td>\n",
       "      <td>23.86</td>\n",
       "      <td>0.00</td>\n",
       "      <td>6.37</td>\n",
       "      <td>4.83</td>\n",
       "      <td>63.91</td>\n",
       "      <td>5.485</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1316</th>\n",
       "      <td>monensin</td>\n",
       "      <td>Launched</td>\n",
       "      <td>infectious disease</td>\n",
       "      <td>gastrointestinal parasites</td>\n",
       "      <td>bacterial permeability inducer</td>\n",
       "      <td>7.60</td>\n",
       "      <td>6.112</td>\n",
       "      <td>6.05</td>\n",
       "      <td>-5.9</td>\n",
       "      <td>-6.33</td>\n",
       "      <td>...</td>\n",
       "      <td>20.93</td>\n",
       "      <td>35.38</td>\n",
       "      <td>0.00</td>\n",
       "      <td>266.61</td>\n",
       "      <td>132.54</td>\n",
       "      <td>26.46</td>\n",
       "      <td>0.00</td>\n",
       "      <td>22.39</td>\n",
       "      <td>156.20</td>\n",
       "      <td>5.520</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1587</th>\n",
       "      <td>MK-1064</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>orexin receptor antagonist</td>\n",
       "      <td>7.69</td>\n",
       "      <td>6.738</td>\n",
       "      <td>7.32</td>\n",
       "      <td>-6.2</td>\n",
       "      <td>-6.41</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>70.77</td>\n",
       "      <td>204.24</td>\n",
       "      <td>67.65</td>\n",
       "      <td>23.86</td>\n",
       "      <td>18.01</td>\n",
       "      <td>11.88</td>\n",
       "      <td>5.26</td>\n",
       "      <td>99.12</td>\n",
       "      <td>5.640</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1640</th>\n",
       "      <td>sulindac</td>\n",
       "      <td>Launched</td>\n",
       "      <td>rheumatology</td>\n",
       "      <td>ankylosing spondylitis</td>\n",
       "      <td>cyclooxygenase inhibitor</td>\n",
       "      <td>7.93</td>\n",
       "      <td>6.441</td>\n",
       "      <td>6.81</td>\n",
       "      <td>-6.2</td>\n",
       "      <td>-6.37</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>36.43</td>\n",
       "      <td>129.87</td>\n",
       "      <td>48.29</td>\n",
       "      <td>90.63</td>\n",
       "      <td>10.67</td>\n",
       "      <td>6.37</td>\n",
       "      <td>19.11</td>\n",
       "      <td>76.41</td>\n",
       "      <td>5.135</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1957</th>\n",
       "      <td>perfluorodecalin</td>\n",
       "      <td>Launched</td>\n",
       "      <td>dermatology</td>\n",
       "      <td>cosmetic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>8.07</td>\n",
       "      <td>7.683</td>\n",
       "      <td>8.05</td>\n",
       "      <td>-7.1</td>\n",
       "      <td>-7.30</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>269.28</td>\n",
       "      <td>0.00</td>\n",
       "      <td>14.59</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>5.275</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1975</th>\n",
       "      <td>cycloheximide</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>protein synthesis inhibitor</td>\n",
       "      <td>7.80</td>\n",
       "      <td>6.698</td>\n",
       "      <td>7.80</td>\n",
       "      <td>-6.1</td>\n",
       "      <td>-6.23</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>66.65</td>\n",
       "      <td>71.59</td>\n",
       "      <td>35.65</td>\n",
       "      <td>0.00</td>\n",
       "      <td>16.21</td>\n",
       "      <td>83.47</td>\n",
       "      <td>4.950</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2096</th>\n",
       "      <td>andarine</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>androgen receptor modulator</td>\n",
       "      <td>7.53</td>\n",
       "      <td>7.326</td>\n",
       "      <td>7.06</td>\n",
       "      <td>-6.0</td>\n",
       "      <td>-6.18</td>\n",
       "      <td>...</td>\n",
       "      <td>71.86</td>\n",
       "      <td>0.00</td>\n",
       "      <td>123.50</td>\n",
       "      <td>125.05</td>\n",
       "      <td>54.81</td>\n",
       "      <td>58.69</td>\n",
       "      <td>44.29</td>\n",
       "      <td>31.44</td>\n",
       "      <td>133.48</td>\n",
       "      <td>5.175</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2227</th>\n",
       "      <td>BMS-906024</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>gamma secretase inhibitor</td>\n",
       "      <td>7.90</td>\n",
       "      <td>7.231</td>\n",
       "      <td>7.43</td>\n",
       "      <td>-6.5</td>\n",
       "      <td>-6.59</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>49.68</td>\n",
       "      <td>158.79</td>\n",
       "      <td>92.52</td>\n",
       "      <td>71.59</td>\n",
       "      <td>45.48</td>\n",
       "      <td>35.65</td>\n",
       "      <td>18.53</td>\n",
       "      <td>104.86</td>\n",
       "      <td>5.680</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2408</th>\n",
       "      <td>olmesartan-medoxomil</td>\n",
       "      <td>Launched</td>\n",
       "      <td>cardiology</td>\n",
       "      <td>hypertension</td>\n",
       "      <td>angiotensin receptor antagonist</td>\n",
       "      <td>7.52</td>\n",
       "      <td>5.538</td>\n",
       "      <td>4.87</td>\n",
       "      <td>-5.9</td>\n",
       "      <td>-6.08</td>\n",
       "      <td>...</td>\n",
       "      <td>20.93</td>\n",
       "      <td>29.36</td>\n",
       "      <td>153.03</td>\n",
       "      <td>175.61</td>\n",
       "      <td>80.72</td>\n",
       "      <td>0.00</td>\n",
       "      <td>11.88</td>\n",
       "      <td>38.48</td>\n",
       "      <td>138.55</td>\n",
       "      <td>5.650</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2677</th>\n",
       "      <td>TAK-063</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>phosphodiesterase inhibitor</td>\n",
       "      <td>8.48</td>\n",
       "      <td>7.434</td>\n",
       "      <td>7.70</td>\n",
       "      <td>-6.2</td>\n",
       "      <td>-6.44</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>57.29</td>\n",
       "      <td>250.80</td>\n",
       "      <td>17.72</td>\n",
       "      <td>34.86</td>\n",
       "      <td>12.12</td>\n",
       "      <td>8.27</td>\n",
       "      <td>8.44</td>\n",
       "      <td>77.54</td>\n",
       "      <td>5.715</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2785</th>\n",
       "      <td>PF-477736</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CHK inhibitor</td>\n",
       "      <td>9.06</td>\n",
       "      <td>7.944</td>\n",
       "      <td>7.64</td>\n",
       "      <td>-6.7</td>\n",
       "      <td>-6.91</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>16.66</td>\n",
       "      <td>80.37</td>\n",
       "      <td>35.65</td>\n",
       "      <td>47.72</td>\n",
       "      <td>71.98</td>\n",
       "      <td>31.43</td>\n",
       "      <td>10.52</td>\n",
       "      <td>131.81</td>\n",
       "      <td>5.600</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2873</th>\n",
       "      <td>obeticholic-acid</td>\n",
       "      <td>Launched</td>\n",
       "      <td>gastroenterology</td>\n",
       "      <td>primary biliary cholangitis</td>\n",
       "      <td>FXR agonist</td>\n",
       "      <td>7.67</td>\n",
       "      <td>4.853</td>\n",
       "      <td>3.13</td>\n",
       "      <td>-6.1</td>\n",
       "      <td>-6.37</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>133.30</td>\n",
       "      <td>66.55</td>\n",
       "      <td>30.88</td>\n",
       "      <td>0.00</td>\n",
       "      <td>1.46</td>\n",
       "      <td>80.59</td>\n",
       "      <td>5.485</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2887</th>\n",
       "      <td>SCH-58261</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>adenosine receptor antagonist</td>\n",
       "      <td>7.78</td>\n",
       "      <td>7.108</td>\n",
       "      <td>7.42</td>\n",
       "      <td>-6.3</td>\n",
       "      <td>-6.37</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>45.16</td>\n",
       "      <td>173.91</td>\n",
       "      <td>20.77</td>\n",
       "      <td>9.51</td>\n",
       "      <td>0.00</td>\n",
       "      <td>48.52</td>\n",
       "      <td>1.90</td>\n",
       "      <td>100.05</td>\n",
       "      <td>5.880</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3008</th>\n",
       "      <td>PIK-293</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PI3K inhibitor</td>\n",
       "      <td>7.53</td>\n",
       "      <td>6.338</td>\n",
       "      <td>6.50</td>\n",
       "      <td>-7.3</td>\n",
       "      <td>-7.60</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>16.79</td>\n",
       "      <td>161.79</td>\n",
       "      <td>92.93</td>\n",
       "      <td>23.86</td>\n",
       "      <td>3.12</td>\n",
       "      <td>12.13</td>\n",
       "      <td>7.59</td>\n",
       "      <td>102.29</td>\n",
       "      <td>6.045</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3035</th>\n",
       "      <td>SP-100030</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NFkB pathway inhibitor</td>\n",
       "      <td>7.75</td>\n",
       "      <td>6.767</td>\n",
       "      <td>6.82</td>\n",
       "      <td>-6.3</td>\n",
       "      <td>-6.59</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>70.14</td>\n",
       "      <td>176.55</td>\n",
       "      <td>23.86</td>\n",
       "      <td>23.28</td>\n",
       "      <td>20.77</td>\n",
       "      <td>5.26</td>\n",
       "      <td>54.88</td>\n",
       "      <td>5.485</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3147</th>\n",
       "      <td>dienogest</td>\n",
       "      <td>Launched</td>\n",
       "      <td>endocrinology</td>\n",
       "      <td>contraceptive</td>\n",
       "      <td>progesterone receptor agonist</td>\n",
       "      <td>8.70</td>\n",
       "      <td>5.560</td>\n",
       "      <td>4.42</td>\n",
       "      <td>-5.9</td>\n",
       "      <td>-6.26</td>\n",
       "      <td>...</td>\n",
       "      <td>47.66</td>\n",
       "      <td>9.56</td>\n",
       "      <td>17.64</td>\n",
       "      <td>33.33</td>\n",
       "      <td>23.86</td>\n",
       "      <td>8.82</td>\n",
       "      <td>0.00</td>\n",
       "      <td>5.69</td>\n",
       "      <td>61.09</td>\n",
       "      <td>5.630</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3176</th>\n",
       "      <td>AZD2461</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>PARP inhibitor</td>\n",
       "      <td>7.58</td>\n",
       "      <td>6.864</td>\n",
       "      <td>7.58</td>\n",
       "      <td>-6.7</td>\n",
       "      <td>-6.88</td>\n",
       "      <td>...</td>\n",
       "      <td>36.88</td>\n",
       "      <td>54.25</td>\n",
       "      <td>128.65</td>\n",
       "      <td>14.96</td>\n",
       "      <td>77.55</td>\n",
       "      <td>9.12</td>\n",
       "      <td>5.15</td>\n",
       "      <td>42.14</td>\n",
       "      <td>78.38</td>\n",
       "      <td>4.890</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3183</th>\n",
       "      <td>TEPP-46</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>pyruvate kinase isozyme activator</td>\n",
       "      <td>7.89</td>\n",
       "      <td>7.181</td>\n",
       "      <td>6.72</td>\n",
       "      <td>-5.8</td>\n",
       "      <td>-6.09</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>48.35</td>\n",
       "      <td>91.11</td>\n",
       "      <td>85.37</td>\n",
       "      <td>47.95</td>\n",
       "      <td>0.00</td>\n",
       "      <td>5.65</td>\n",
       "      <td>5.26</td>\n",
       "      <td>99.90</td>\n",
       "      <td>5.660</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3373</th>\n",
       "      <td>candesartan</td>\n",
       "      <td>Launched</td>\n",
       "      <td>cardiology</td>\n",
       "      <td>congestive heart failure</td>\n",
       "      <td>angiotensin receptor antagonist</td>\n",
       "      <td>7.80</td>\n",
       "      <td>5.861</td>\n",
       "      <td>5.02</td>\n",
       "      <td>-5.9</td>\n",
       "      <td>-6.14</td>\n",
       "      <td>...</td>\n",
       "      <td>20.93</td>\n",
       "      <td>0.00</td>\n",
       "      <td>210.25</td>\n",
       "      <td>56.15</td>\n",
       "      <td>66.55</td>\n",
       "      <td>0.00</td>\n",
       "      <td>16.17</td>\n",
       "      <td>22.39</td>\n",
       "      <td>105.85</td>\n",
       "      <td>5.085</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3640</th>\n",
       "      <td>L-701324</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>glutamate receptor antagonist</td>\n",
       "      <td>7.98</td>\n",
       "      <td>5.621</td>\n",
       "      <td>4.88</td>\n",
       "      <td>-6.3</td>\n",
       "      <td>-6.50</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>211.72</td>\n",
       "      <td>52.39</td>\n",
       "      <td>47.72</td>\n",
       "      <td>0.00</td>\n",
       "      <td>20.77</td>\n",
       "      <td>10.95</td>\n",
       "      <td>55.40</td>\n",
       "      <td>5.805</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3651</th>\n",
       "      <td>INT-767</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>FXR agonist</td>\n",
       "      <td>7.70</td>\n",
       "      <td>4.408</td>\n",
       "      <td>5.67</td>\n",
       "      <td>-6.7</td>\n",
       "      <td>-6.88</td>\n",
       "      <td>...</td>\n",
       "      <td>20.93</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>133.30</td>\n",
       "      <td>80.80</td>\n",
       "      <td>30.88</td>\n",
       "      <td>0.00</td>\n",
       "      <td>20.93</td>\n",
       "      <td>100.90</td>\n",
       "      <td>5.450</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4364</th>\n",
       "      <td>RU-28318</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>cytochrome P450 inhibitor</td>\n",
       "      <td>8.11</td>\n",
       "      <td>6.457</td>\n",
       "      <td>5.44</td>\n",
       "      <td>-6.0</td>\n",
       "      <td>-6.15</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3.19</td>\n",
       "      <td>17.64</td>\n",
       "      <td>99.98</td>\n",
       "      <td>90.41</td>\n",
       "      <td>17.64</td>\n",
       "      <td>0.00</td>\n",
       "      <td>7.15</td>\n",
       "      <td>77.43</td>\n",
       "      <td>5.455</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4615</th>\n",
       "      <td>ITX3</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>GEF inhibitor</td>\n",
       "      <td>7.85</td>\n",
       "      <td>6.658</td>\n",
       "      <td>6.82</td>\n",
       "      <td>-5.8</td>\n",
       "      <td>-6.06</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>2.24</td>\n",
       "      <td>183.48</td>\n",
       "      <td>98.87</td>\n",
       "      <td>23.86</td>\n",
       "      <td>0.69</td>\n",
       "      <td>7.05</td>\n",
       "      <td>22.90</td>\n",
       "      <td>39.82</td>\n",
       "      <td>5.875</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4624</th>\n",
       "      <td>navarixin</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>CC chemokine receptor antagonist</td>\n",
       "      <td>7.66</td>\n",
       "      <td>6.686</td>\n",
       "      <td>6.87</td>\n",
       "      <td>-6.2</td>\n",
       "      <td>-6.35</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>80.82</td>\n",
       "      <td>88.22</td>\n",
       "      <td>74.65</td>\n",
       "      <td>81.09</td>\n",
       "      <td>18.01</td>\n",
       "      <td>20.77</td>\n",
       "      <td>16.63</td>\n",
       "      <td>111.88</td>\n",
       "      <td>5.510</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4779</th>\n",
       "      <td>I-BRD9</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>bromodomain inhibitor</td>\n",
       "      <td>8.15</td>\n",
       "      <td>6.492</td>\n",
       "      <td>7.17</td>\n",
       "      <td>-6.2</td>\n",
       "      <td>-6.48</td>\n",
       "      <td>...</td>\n",
       "      <td>56.09</td>\n",
       "      <td>0.00</td>\n",
       "      <td>105.43</td>\n",
       "      <td>109.48</td>\n",
       "      <td>72.03</td>\n",
       "      <td>28.96</td>\n",
       "      <td>0.00</td>\n",
       "      <td>60.49</td>\n",
       "      <td>92.07</td>\n",
       "      <td>6.010</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4797</th>\n",
       "      <td>sanguinarium-chloride</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>apoptosis stimulant</td>\n",
       "      <td>7.53</td>\n",
       "      <td>6.427</td>\n",
       "      <td>5.90</td>\n",
       "      <td>-6.5</td>\n",
       "      <td>-6.79</td>\n",
       "      <td>...</td>\n",
       "      <td>45.97</td>\n",
       "      <td>0.00</td>\n",
       "      <td>138.08</td>\n",
       "      <td>53.87</td>\n",
       "      <td>1.90</td>\n",
       "      <td>0.00</td>\n",
       "      <td>15.01</td>\n",
       "      <td>45.97</td>\n",
       "      <td>40.80</td>\n",
       "      <td>5.875</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4915</th>\n",
       "      <td>resmetirom</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>thyroid hormone receptor agonist</td>\n",
       "      <td>8.02</td>\n",
       "      <td>7.223</td>\n",
       "      <td>7.32</td>\n",
       "      <td>-6.0</td>\n",
       "      <td>-6.18</td>\n",
       "      <td>...</td>\n",
       "      <td>47.66</td>\n",
       "      <td>33.45</td>\n",
       "      <td>52.93</td>\n",
       "      <td>181.63</td>\n",
       "      <td>109.23</td>\n",
       "      <td>3.00</td>\n",
       "      <td>2.76</td>\n",
       "      <td>7.59</td>\n",
       "      <td>149.95</td>\n",
       "      <td>5.485</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5042</th>\n",
       "      <td>K-strophanthidin</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ATPase inhibitor</td>\n",
       "      <td>8.17</td>\n",
       "      <td>6.026</td>\n",
       "      <td>6.14</td>\n",
       "      <td>-6.2</td>\n",
       "      <td>-6.55</td>\n",
       "      <td>...</td>\n",
       "      <td>20.93</td>\n",
       "      <td>3.19</td>\n",
       "      <td>17.64</td>\n",
       "      <td>33.33</td>\n",
       "      <td>58.72</td>\n",
       "      <td>13.23</td>\n",
       "      <td>0.00</td>\n",
       "      <td>28.67</td>\n",
       "      <td>104.06</td>\n",
       "      <td>5.515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5249</th>\n",
       "      <td>evodiamine</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>ATPase inhibitor  TRPV agonist</td>\n",
       "      <td>7.74</td>\n",
       "      <td>6.570</td>\n",
       "      <td>6.61</td>\n",
       "      <td>-6.1</td>\n",
       "      <td>-6.40</td>\n",
       "      <td>...</td>\n",
       "      <td>18.44</td>\n",
       "      <td>51.77</td>\n",
       "      <td>145.86</td>\n",
       "      <td>2.76</td>\n",
       "      <td>23.86</td>\n",
       "      <td>19.91</td>\n",
       "      <td>7.47</td>\n",
       "      <td>23.70</td>\n",
       "      <td>39.34</td>\n",
       "      <td>5.650</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5296</th>\n",
       "      <td>palmatine-chloride</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>dopamine synthesis inhibitor</td>\n",
       "      <td>7.66</td>\n",
       "      <td>6.585</td>\n",
       "      <td>4.92</td>\n",
       "      <td>-5.7</td>\n",
       "      <td>-6.02</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>160.40</td>\n",
       "      <td>116.52</td>\n",
       "      <td>39.41</td>\n",
       "      <td>1.90</td>\n",
       "      <td>0.00</td>\n",
       "      <td>11.09</td>\n",
       "      <td>0.00</td>\n",
       "      <td>40.80</td>\n",
       "      <td>5.955</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5351</th>\n",
       "      <td>hypericin</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>tyrosine kinase inhibitor</td>\n",
       "      <td>7.51</td>\n",
       "      <td>5.486</td>\n",
       "      <td>5.55</td>\n",
       "      <td>-6.5</td>\n",
       "      <td>-6.86</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>96.30</td>\n",
       "      <td>82.38</td>\n",
       "      <td>175.77</td>\n",
       "      <td>0.00</td>\n",
       "      <td>25.73</td>\n",
       "      <td>11.38</td>\n",
       "      <td>164.01</td>\n",
       "      <td>5.185</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5534</th>\n",
       "      <td>epinastine</td>\n",
       "      <td>Launched</td>\n",
       "      <td>ophthalmology</td>\n",
       "      <td>conjunctivitis</td>\n",
       "      <td>histamine receptor antagonist</td>\n",
       "      <td>7.79</td>\n",
       "      <td>5.444</td>\n",
       "      <td>4.22</td>\n",
       "      <td>-5.8</td>\n",
       "      <td>-6.09</td>\n",
       "      <td>...</td>\n",
       "      <td>18.44</td>\n",
       "      <td>18.87</td>\n",
       "      <td>141.15</td>\n",
       "      <td>2.76</td>\n",
       "      <td>16.79</td>\n",
       "      <td>3.12</td>\n",
       "      <td>35.65</td>\n",
       "      <td>20.34</td>\n",
       "      <td>43.23</td>\n",
       "      <td>5.860</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5556</th>\n",
       "      <td>narasin</td>\n",
       "      <td>Launched</td>\n",
       "      <td>infectious disease</td>\n",
       "      <td>coccidiosis</td>\n",
       "      <td>antiprotozoal agent</td>\n",
       "      <td>7.53</td>\n",
       "      <td>7.256</td>\n",
       "      <td>6.92</td>\n",
       "      <td>-5.8</td>\n",
       "      <td>-6.11</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>35.29</td>\n",
       "      <td>366.59</td>\n",
       "      <td>145.41</td>\n",
       "      <td>35.29</td>\n",
       "      <td>0.00</td>\n",
       "      <td>7.15</td>\n",
       "      <td>164.04</td>\n",
       "      <td>5.590</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5630</th>\n",
       "      <td>TC-S-7009</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>hypoxia inducible factor inhibitor</td>\n",
       "      <td>7.70</td>\n",
       "      <td>7.351</td>\n",
       "      <td>7.34</td>\n",
       "      <td>-6.1</td>\n",
       "      <td>-6.23</td>\n",
       "      <td>...</td>\n",
       "      <td>50.94</td>\n",
       "      <td>9.96</td>\n",
       "      <td>92.50</td>\n",
       "      <td>62.38</td>\n",
       "      <td>17.05</td>\n",
       "      <td>60.06</td>\n",
       "      <td>30.57</td>\n",
       "      <td>0.00</td>\n",
       "      <td>96.77</td>\n",
       "      <td>5.850</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5873</th>\n",
       "      <td>CPI-0610</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>bromodomain inhibitor</td>\n",
       "      <td>7.77</td>\n",
       "      <td>5.579</td>\n",
       "      <td>7.77</td>\n",
       "      <td>-6.1</td>\n",
       "      <td>-6.28</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>26.52</td>\n",
       "      <td>147.52</td>\n",
       "      <td>72.47</td>\n",
       "      <td>33.60</td>\n",
       "      <td>0.00</td>\n",
       "      <td>39.27</td>\n",
       "      <td>8.02</td>\n",
       "      <td>81.48</td>\n",
       "      <td>5.735</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5936</th>\n",
       "      <td>tivantinib</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>tyrosine kinase inhibitor</td>\n",
       "      <td>7.84</td>\n",
       "      <td>6.432</td>\n",
       "      <td>6.80</td>\n",
       "      <td>-6.9</td>\n",
       "      <td>-7.08</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>18.87</td>\n",
       "      <td>167.37</td>\n",
       "      <td>18.44</td>\n",
       "      <td>47.72</td>\n",
       "      <td>34.80</td>\n",
       "      <td>9.43</td>\n",
       "      <td>10.52</td>\n",
       "      <td>66.89</td>\n",
       "      <td>5.790</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6199</th>\n",
       "      <td>PF-04217903</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>c-Met inhibitor</td>\n",
       "      <td>8.03</td>\n",
       "      <td>6.561</td>\n",
       "      <td>6.89</td>\n",
       "      <td>-6.4</td>\n",
       "      <td>-6.66</td>\n",
       "      <td>...</td>\n",
       "      <td>20.93</td>\n",
       "      <td>0.00</td>\n",
       "      <td>171.16</td>\n",
       "      <td>36.88</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>14.09</td>\n",
       "      <td>20.93</td>\n",
       "      <td>107.43</td>\n",
       "      <td>5.520</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>41 rows × 55 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              compound_name clinical_phase        disease_area  \\\n",
       "586                indiplon        Phase 3                 NaN   \n",
       "769          sulfinpyrazone       Launched        rheumatology   \n",
       "1116             ilaprazole       Launched    gastroenterology   \n",
       "1204                  SPP86    Preclinical                 NaN   \n",
       "1216              LY2183240    Preclinical                 NaN   \n",
       "1316               monensin       Launched  infectious disease   \n",
       "1587                MK-1064        Phase 1                 NaN   \n",
       "1640               sulindac       Launched        rheumatology   \n",
       "1957       perfluorodecalin       Launched         dermatology   \n",
       "1975          cycloheximide    Preclinical                 NaN   \n",
       "2096               andarine        Phase 1                 NaN   \n",
       "2227             BMS-906024        Phase 1                 NaN   \n",
       "2408   olmesartan-medoxomil       Launched          cardiology   \n",
       "2677                TAK-063        Phase 2                 NaN   \n",
       "2785              PF-477736        Phase 1                 NaN   \n",
       "2873       obeticholic-acid       Launched    gastroenterology   \n",
       "2887              SCH-58261    Preclinical                 NaN   \n",
       "3008                PIK-293    Preclinical                 NaN   \n",
       "3035              SP-100030    Preclinical                 NaN   \n",
       "3147              dienogest       Launched       endocrinology   \n",
       "3176                AZD2461        Phase 1                 NaN   \n",
       "3183                TEPP-46    Preclinical                 NaN   \n",
       "3373            candesartan       Launched          cardiology   \n",
       "3640               L-701324    Preclinical                 NaN   \n",
       "3651                INT-767        Phase 1                 NaN   \n",
       "4364               RU-28318        Phase 2                 NaN   \n",
       "4615                   ITX3    Preclinical                 NaN   \n",
       "4624              navarixin        Phase 2                 NaN   \n",
       "4779                 I-BRD9    Preclinical                 NaN   \n",
       "4797  sanguinarium-chloride        Phase 1                 NaN   \n",
       "4915             resmetirom        Phase 3                 NaN   \n",
       "5042       K-strophanthidin        Phase 2                 NaN   \n",
       "5249             evodiamine    Preclinical                 NaN   \n",
       "5296     palmatine-chloride    Preclinical                 NaN   \n",
       "5351              hypericin        Phase 3                 NaN   \n",
       "5534             epinastine       Launched       ophthalmology   \n",
       "5556                narasin       Launched  infectious disease   \n",
       "5630              TC-S-7009    Preclinical                 NaN   \n",
       "5873               CPI-0610        Phase 2                 NaN   \n",
       "5936             tivantinib        Phase 3                 NaN   \n",
       "6199            PF-04217903        Phase 1                 NaN   \n",
       "\n",
       "                                  indication  \\\n",
       "586                                      NaN   \n",
       "769                                     gout   \n",
       "1116  gastroesophageal reflux disease (GERD)   \n",
       "1204                                     NaN   \n",
       "1216                                     NaN   \n",
       "1316              gastrointestinal parasites   \n",
       "1587                                     NaN   \n",
       "1640                  ankylosing spondylitis   \n",
       "1957                                cosmetic   \n",
       "1975                                     NaN   \n",
       "2096                                     NaN   \n",
       "2227                                     NaN   \n",
       "2408                            hypertension   \n",
       "2677                                     NaN   \n",
       "2785                                     NaN   \n",
       "2873             primary biliary cholangitis   \n",
       "2887                                     NaN   \n",
       "3008                                     NaN   \n",
       "3035                                     NaN   \n",
       "3147                           contraceptive   \n",
       "3176                                     NaN   \n",
       "3183                                     NaN   \n",
       "3373                congestive heart failure   \n",
       "3640                                     NaN   \n",
       "3651                                     NaN   \n",
       "4364                                     NaN   \n",
       "4615                                     NaN   \n",
       "4624                                     NaN   \n",
       "4779                                     NaN   \n",
       "4797                                     NaN   \n",
       "4915                                     NaN   \n",
       "5042                                     NaN   \n",
       "5249                                     NaN   \n",
       "5296                                     NaN   \n",
       "5351                                     NaN   \n",
       "5534                          conjunctivitis   \n",
       "5556                             coccidiosis   \n",
       "5630                                     NaN   \n",
       "5873                                     NaN   \n",
       "5936                                     NaN   \n",
       "6199                                     NaN   \n",
       "\n",
       "                             mechanism_of_action  cf_max_score  cf_avg_score  \\\n",
       "586              benzodiazepine receptor agonist          7.91         7.006   \n",
       "769                           uricosuric blocker          7.90         6.700   \n",
       "1116                       proton pump inhibitor          8.09         6.908   \n",
       "1204  receptor tyrosine protein kinase inhibitor          8.32         6.542   \n",
       "1216     FAAH inhibitor  FAAH reuptake inhibitor          8.66         7.416   \n",
       "1316              bacterial permeability inducer          7.60         6.112   \n",
       "1587                  orexin receptor antagonist          7.69         6.738   \n",
       "1640                    cyclooxygenase inhibitor          7.93         6.441   \n",
       "1957                                         NaN          8.07         7.683   \n",
       "1975                 protein synthesis inhibitor          7.80         6.698   \n",
       "2096                 androgen receptor modulator          7.53         7.326   \n",
       "2227                   gamma secretase inhibitor          7.90         7.231   \n",
       "2408             angiotensin receptor antagonist          7.52         5.538   \n",
       "2677                 phosphodiesterase inhibitor          8.48         7.434   \n",
       "2785                               CHK inhibitor          9.06         7.944   \n",
       "2873                                 FXR agonist          7.67         4.853   \n",
       "2887               adenosine receptor antagonist          7.78         7.108   \n",
       "3008                              PI3K inhibitor          7.53         6.338   \n",
       "3035                      NFkB pathway inhibitor          7.75         6.767   \n",
       "3147               progesterone receptor agonist          8.70         5.560   \n",
       "3176                              PARP inhibitor          7.58         6.864   \n",
       "3183           pyruvate kinase isozyme activator          7.89         7.181   \n",
       "3373             angiotensin receptor antagonist          7.80         5.861   \n",
       "3640               glutamate receptor antagonist          7.98         5.621   \n",
       "3651                                 FXR agonist          7.70         4.408   \n",
       "4364                   cytochrome P450 inhibitor          8.11         6.457   \n",
       "4615                               GEF inhibitor          7.85         6.658   \n",
       "4624            CC chemokine receptor antagonist          7.66         6.686   \n",
       "4779                       bromodomain inhibitor          8.15         6.492   \n",
       "4797                         apoptosis stimulant          7.53         6.427   \n",
       "4915            thyroid hormone receptor agonist          8.02         7.223   \n",
       "5042                            ATPase inhibitor          8.17         6.026   \n",
       "5249              ATPase inhibitor  TRPV agonist          7.74         6.570   \n",
       "5296                dopamine synthesis inhibitor          7.66         6.585   \n",
       "5351                   tyrosine kinase inhibitor          7.51         5.486   \n",
       "5534               histamine receptor antagonist          7.79         5.444   \n",
       "5556                         antiprotozoal agent          7.53         7.256   \n",
       "5630          hypoxia inducible factor inhibitor          7.70         7.351   \n",
       "5873                       bromodomain inhibitor          7.77         5.579   \n",
       "5936                   tyrosine kinase inhibitor          7.84         6.432   \n",
       "6199                             c-Met inhibitor          8.03         6.561   \n",
       "\n",
       "      cf_top_pose  docking_max_score  docking_avg_score  ...  chem_slogp_vsa3  \\\n",
       "586          7.16               -5.9              -6.07  ...             2.76   \n",
       "769          7.31               -6.3              -6.45  ...            17.23   \n",
       "1116         8.09               -6.0              -6.21  ...             0.00   \n",
       "1204         7.30               -5.8              -6.09  ...            34.06   \n",
       "1216         5.36               -6.7              -6.90  ...             0.00   \n",
       "1316         6.05               -5.9              -6.33  ...            20.93   \n",
       "1587         7.32               -6.2              -6.41  ...             0.00   \n",
       "1640         6.81               -6.2              -6.37  ...             0.00   \n",
       "1957         8.05               -7.1              -7.30  ...             0.00   \n",
       "1975         7.80               -6.1              -6.23  ...             0.00   \n",
       "2096         7.06               -6.0              -6.18  ...            71.86   \n",
       "2227         7.43               -6.5              -6.59  ...             0.00   \n",
       "2408         4.87               -5.9              -6.08  ...            20.93   \n",
       "2677         7.70               -6.2              -6.44  ...             0.00   \n",
       "2785         7.64               -6.7              -6.91  ...             0.00   \n",
       "2873         3.13               -6.1              -6.37  ...             0.00   \n",
       "2887         7.42               -6.3              -6.37  ...             0.00   \n",
       "3008         6.50               -7.3              -7.60  ...             0.00   \n",
       "3035         6.82               -6.3              -6.59  ...             0.00   \n",
       "3147         4.42               -5.9              -6.26  ...            47.66   \n",
       "3176         7.58               -6.7              -6.88  ...            36.88   \n",
       "3183         6.72               -5.8              -6.09  ...             0.00   \n",
       "3373         5.02               -5.9              -6.14  ...            20.93   \n",
       "3640         4.88               -6.3              -6.50  ...             0.00   \n",
       "3651         5.67               -6.7              -6.88  ...            20.93   \n",
       "4364         5.44               -6.0              -6.15  ...             0.00   \n",
       "4615         6.82               -5.8              -6.06  ...             0.00   \n",
       "4624         6.87               -6.2              -6.35  ...             0.00   \n",
       "4779         7.17               -6.2              -6.48  ...            56.09   \n",
       "4797         5.90               -6.5              -6.79  ...            45.97   \n",
       "4915         7.32               -6.0              -6.18  ...            47.66   \n",
       "5042         6.14               -6.2              -6.55  ...            20.93   \n",
       "5249         6.61               -6.1              -6.40  ...            18.44   \n",
       "5296         4.92               -5.7              -6.02  ...             0.00   \n",
       "5351         5.55               -6.5              -6.86  ...             0.00   \n",
       "5534         4.22               -5.8              -6.09  ...            18.44   \n",
       "5556         6.92               -5.8              -6.11  ...             0.00   \n",
       "5630         7.34               -6.1              -6.23  ...            50.94   \n",
       "5873         7.77               -6.1              -6.28  ...             0.00   \n",
       "5936         6.80               -6.9              -7.08  ...             0.00   \n",
       "6199         6.89               -6.4              -6.66  ...            20.93   \n",
       "\n",
       "      chem_slogp_vsa5  chem_slogp_vsa7  chem_slogp_vsa9  chem_smr_vsa0  \\\n",
       "586             49.68           156.53            69.69          47.72   \n",
       "769              1.55           264.65             5.51          71.81   \n",
       "1116            36.08           164.55            55.80          24.09   \n",
       "1204             0.00           109.29            68.98           0.00   \n",
       "1216            84.66           165.16            23.86          23.86   \n",
       "1316            35.38             0.00           266.61         132.54   \n",
       "1587            70.77           204.24            67.65          23.86   \n",
       "1640            36.43           129.87            48.29          90.63   \n",
       "1957             0.00             0.00           269.28           0.00   \n",
       "1975             0.00             0.00            66.65          71.59   \n",
       "2096             0.00           123.50           125.05          54.81   \n",
       "2227            49.68           158.79            92.52          71.59   \n",
       "2408            29.36           153.03           175.61          80.72   \n",
       "2677            57.29           250.80            17.72          34.86   \n",
       "2785            16.66            80.37            35.65          47.72   \n",
       "2873             0.00             0.00           133.30          66.55   \n",
       "2887            45.16           173.91            20.77           9.51   \n",
       "3008            16.79           161.79            92.93          23.86   \n",
       "3035             0.00            70.14           176.55          23.86   \n",
       "3147             9.56            17.64            33.33          23.86   \n",
       "3176            54.25           128.65            14.96          77.55   \n",
       "3183            48.35            91.11            85.37          47.95   \n",
       "3373             0.00           210.25            56.15          66.55   \n",
       "3640             0.00           211.72            52.39          47.72   \n",
       "3651             0.00             0.00           133.30          80.80   \n",
       "4364             3.19            17.64            99.98          90.41   \n",
       "4615             2.24           183.48            98.87          23.86   \n",
       "4624            80.82            88.22            74.65          81.09   \n",
       "4779             0.00           105.43           109.48          72.03   \n",
       "4797             0.00           138.08            53.87           1.90   \n",
       "4915            33.45            52.93           181.63         109.23   \n",
       "5042             3.19            17.64            33.33          58.72   \n",
       "5249            51.77           145.86             2.76          23.86   \n",
       "5296           160.40           116.52            39.41           1.90   \n",
       "5351             0.00            96.30            82.38         175.77   \n",
       "5534            18.87           141.15             2.76          16.79   \n",
       "5556             0.00            35.29           366.59         145.41   \n",
       "5630             9.96            92.50            62.38          17.05   \n",
       "5873            26.52           147.52            72.47          33.60   \n",
       "5936            18.87           167.37            18.44          47.72   \n",
       "6199             0.00           171.16            36.88           0.00   \n",
       "\n",
       "      chem_smr_vsa2  chem_smr_vsa4  chem_smr_vsa6  chem_tpsa  cv_safety_score  \n",
       "586            5.88           5.08          10.95      67.56            5.905  \n",
       "769           11.97           5.51          27.75      76.90            5.355  \n",
       "1116          17.48           7.05           0.00      92.01            5.515  \n",
       "1204           0.00           6.62           0.00      69.62            5.760  \n",
       "1216           0.00           6.37           4.83      63.91            5.485  \n",
       "1316          26.46           0.00          22.39     156.20            5.520  \n",
       "1587          18.01          11.88           5.26      99.12            5.640  \n",
       "1640          10.67           6.37          19.11      76.41            5.135  \n",
       "1957          14.59           0.00           0.00       0.00            5.275  \n",
       "1975          35.65           0.00          16.21      83.47            4.950  \n",
       "2096          58.69          44.29          31.44     133.48            5.175  \n",
       "2227          45.48          35.65          18.53     104.86            5.680  \n",
       "2408           0.00          11.88          38.48     138.55            5.650  \n",
       "2677          12.12           8.27           8.44      77.54            5.715  \n",
       "2785          71.98          31.43          10.52     131.81            5.600  \n",
       "2873          30.88           0.00           1.46      80.59            5.485  \n",
       "2887           0.00          48.52           1.90     100.05            5.880  \n",
       "3008           3.12          12.13           7.59     102.29            6.045  \n",
       "3035          23.28          20.77           5.26      54.88            5.485  \n",
       "3147           8.82           0.00           5.69      61.09            5.630  \n",
       "3176           9.12           5.15          42.14      78.38            4.890  \n",
       "3183           0.00           5.65           5.26      99.90            5.660  \n",
       "3373           0.00          16.17          22.39     105.85            5.085  \n",
       "3640           0.00          20.77          10.95      55.40            5.805  \n",
       "3651          30.88           0.00          20.93     100.90            5.450  \n",
       "4364          17.64           0.00           7.15      77.43            5.455  \n",
       "4615           0.69           7.05          22.90      39.82            5.875  \n",
       "4624          18.01          20.77          16.63     111.88            5.510  \n",
       "4779          28.96           0.00          60.49      92.07            6.010  \n",
       "4797           0.00          15.01          45.97      40.80            5.875  \n",
       "4915           3.00           2.76           7.59     149.95            5.485  \n",
       "5042          13.23           0.00          28.67     104.06            5.515  \n",
       "5249          19.91           7.47          23.70      39.34            5.650  \n",
       "5296           0.00          11.09           0.00      40.80            5.955  \n",
       "5351           0.00          25.73          11.38     164.01            5.185  \n",
       "5534           3.12          35.65          20.34      43.23            5.860  \n",
       "5556          35.29           0.00           7.15     164.04            5.590  \n",
       "5630          60.06          30.57           0.00      96.77            5.850  \n",
       "5873           0.00          39.27           8.02      81.48            5.735  \n",
       "5936          34.80           9.43          10.52      66.89            5.790  \n",
       "6199           0.00          14.09          20.93     107.43            5.520  \n",
       "\n",
       "[41 rows x 55 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "found_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "e4f0f97c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "compound_name                                     0\n",
       "clinical_phase                                    0\n",
       "disease_area                                   4310\n",
       "indication                                     4310\n",
       "mechanism_of_action                             483\n",
       "cf_max_score                                     60\n",
       "cf_avg_score                                     60\n",
       "cf_top_pose                                      60\n",
       "docking_max_score                                60\n",
       "docking_avg_score                                60\n",
       "docking_top_pose                                 60\n",
       "safety_Aurora kinase A                            0\n",
       "safety_Bile Salt Export Pump model 2              0\n",
       "safety_Caspase 3                                  0\n",
       "safety_Cathepsin L1                               0\n",
       "safety_hERG_pIC50                                 0\n",
       "safety_KCNA5                                      0\n",
       "safety_Muscarinic acetylcholine receptor M1       0\n",
       "safety_Muscarinic acetylcholine receptor M3       0\n",
       "hERG_pIC50                                        0\n",
       "KCNA5                                             0\n",
       "pk_Human microsomal clearance model 2             0\n",
       "chem_a_acc                                        0\n",
       "chem_a_don                                        0\n",
       "chem_chi0                                         0\n",
       "chem_chi1                                         0\n",
       "chem_chi0_c                                       0\n",
       "chem_chi1_c                                       0\n",
       "chem_kier1                                        0\n",
       "chem_lip_acc                                      0\n",
       "chem_npr1                                         0\n",
       "chem_peoe_pcplus                                  0\n",
       "chem_peoe_vsaplus0                                0\n",
       "chem_peoe_vsaplus2                                0\n",
       "chem_peoe_vsaplus4                                0\n",
       "chem_peoe_vsaplus6                                0\n",
       "chem_peoe_vsaminus1                               0\n",
       "chem_peoe_vsaminus3                               0\n",
       "chem_peoe_vsaminus5                               0\n",
       "chem_pmi                                          0\n",
       "chem_pmi2                                         0\n",
       "chem_pmix                                         0\n",
       "chem_pmiz                                         0\n",
       "chem_slogp                                        0\n",
       "chem_slogp_vsa1                                   0\n",
       "chem_slogp_vsa3                                   0\n",
       "chem_slogp_vsa5                                   0\n",
       "chem_slogp_vsa7                                   0\n",
       "chem_slogp_vsa9                                   0\n",
       "chem_smr_vsa0                                     0\n",
       "chem_smr_vsa2                                     0\n",
       "chem_smr_vsa4                                     0\n",
       "chem_smr_vsa6                                     0\n",
       "chem_tpsa                                         0\n",
       "cv_safety_score                                   0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "39ce0c8c",
   "metadata": {},
   "outputs": [],
   "source": [
    "data_less_null = data.drop(columns=['disease_area', 'indication'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "13d7904a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>compound_name</th>\n",
       "      <th>clinical_phase</th>\n",
       "      <th>mechanism_of_action</th>\n",
       "      <th>cf_max_score</th>\n",
       "      <th>cf_avg_score</th>\n",
       "      <th>cf_top_pose</th>\n",
       "      <th>docking_max_score</th>\n",
       "      <th>docking_avg_score</th>\n",
       "      <th>docking_top_pose</th>\n",
       "      <th>safety_Aurora kinase A</th>\n",
       "      <th>...</th>\n",
       "      <th>chem_slogp_vsa3</th>\n",
       "      <th>chem_slogp_vsa5</th>\n",
       "      <th>chem_slogp_vsa7</th>\n",
       "      <th>chem_slogp_vsa9</th>\n",
       "      <th>chem_smr_vsa0</th>\n",
       "      <th>chem_smr_vsa2</th>\n",
       "      <th>chem_smr_vsa4</th>\n",
       "      <th>chem_smr_vsa6</th>\n",
       "      <th>chem_tpsa</th>\n",
       "      <th>cv_safety_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>lersivirine</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>non-nucleoside reverse transcriptase inhibitor</td>\n",
       "      <td>6.29</td>\n",
       "      <td>5.747</td>\n",
       "      <td>5.87</td>\n",
       "      <td>-5.2</td>\n",
       "      <td>-5.45</td>\n",
       "      <td>-5.6</td>\n",
       "      <td>4.35</td>\n",
       "      <td>...</td>\n",
       "      <td>116.25</td>\n",
       "      <td>37.74</td>\n",
       "      <td>52.93</td>\n",
       "      <td>95.58</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>20.93</td>\n",
       "      <td>94.86</td>\n",
       "      <td>5.670</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>radafaxine</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>dopamine-norepinephrine reuptake inhibitor</td>\n",
       "      <td>6.81</td>\n",
       "      <td>5.670</td>\n",
       "      <td>5.27</td>\n",
       "      <td>-4.9</td>\n",
       "      <td>-5.08</td>\n",
       "      <td>-5.5</td>\n",
       "      <td>5.40</td>\n",
       "      <td>...</td>\n",
       "      <td>20.93</td>\n",
       "      <td>0.00</td>\n",
       "      <td>70.57</td>\n",
       "      <td>139.13</td>\n",
       "      <td>11.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>20.93</td>\n",
       "      <td>46.07</td>\n",
       "      <td>5.695</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>telcagepant</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>calcitonin antagonist</td>\n",
       "      <td>6.12</td>\n",
       "      <td>5.429</td>\n",
       "      <td>5.04</td>\n",
       "      <td>-5.4</td>\n",
       "      <td>-5.66</td>\n",
       "      <td>-6.1</td>\n",
       "      <td>5.65</td>\n",
       "      <td>...</td>\n",
       "      <td>73.76</td>\n",
       "      <td>0.00</td>\n",
       "      <td>105.43</td>\n",
       "      <td>127.61</td>\n",
       "      <td>71.59</td>\n",
       "      <td>47.14</td>\n",
       "      <td>23.10</td>\n",
       "      <td>88.68</td>\n",
       "      <td>97.88</td>\n",
       "      <td>5.770</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>benzenemethanol</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6.78</td>\n",
       "      <td>5.522</td>\n",
       "      <td>5.67</td>\n",
       "      <td>-4.2</td>\n",
       "      <td>-4.49</td>\n",
       "      <td>-4.8</td>\n",
       "      <td>4.52</td>\n",
       "      <td>...</td>\n",
       "      <td>18.44</td>\n",
       "      <td>0.00</td>\n",
       "      <td>52.93</td>\n",
       "      <td>133.30</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>18.44</td>\n",
       "      <td>36.84</td>\n",
       "      <td>5.125</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>mitoxantrone</td>\n",
       "      <td>Launched</td>\n",
       "      <td>topoisomerase inhibitor</td>\n",
       "      <td>6.09</td>\n",
       "      <td>5.593</td>\n",
       "      <td>5.88</td>\n",
       "      <td>-4.8</td>\n",
       "      <td>-4.89</td>\n",
       "      <td>-5.2</td>\n",
       "      <td>5.78</td>\n",
       "      <td>...</td>\n",
       "      <td>152.49</td>\n",
       "      <td>0.00</td>\n",
       "      <td>70.57</td>\n",
       "      <td>10.76</td>\n",
       "      <td>90.41</td>\n",
       "      <td>0.00</td>\n",
       "      <td>41.53</td>\n",
       "      <td>163.87</td>\n",
       "      <td>175.17</td>\n",
       "      <td>4.895</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6368</th>\n",
       "      <td>clofedanol</td>\n",
       "      <td>Launched</td>\n",
       "      <td>histamine receptor antagonist</td>\n",
       "      <td>6.49</td>\n",
       "      <td>5.661</td>\n",
       "      <td>6.00</td>\n",
       "      <td>-4.9</td>\n",
       "      <td>-5.07</td>\n",
       "      <td>-5.5</td>\n",
       "      <td>5.51</td>\n",
       "      <td>...</td>\n",
       "      <td>18.44</td>\n",
       "      <td>65.79</td>\n",
       "      <td>158.79</td>\n",
       "      <td>39.15</td>\n",
       "      <td>3.12</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>18.44</td>\n",
       "      <td>24.67</td>\n",
       "      <td>5.500</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6369</th>\n",
       "      <td>Debio-0932</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>HSP inhibitor</td>\n",
       "      <td>6.78</td>\n",
       "      <td>5.252</td>\n",
       "      <td>4.40</td>\n",
       "      <td>-4.6</td>\n",
       "      <td>-4.74</td>\n",
       "      <td>-4.9</td>\n",
       "      <td>5.91</td>\n",
       "      <td>...</td>\n",
       "      <td>59.86</td>\n",
       "      <td>68.04</td>\n",
       "      <td>74.43</td>\n",
       "      <td>166.21</td>\n",
       "      <td>16.79</td>\n",
       "      <td>5.37</td>\n",
       "      <td>9.37</td>\n",
       "      <td>59.86</td>\n",
       "      <td>96.29</td>\n",
       "      <td>6.280</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6370</th>\n",
       "      <td>eptifibatide</td>\n",
       "      <td>Launched</td>\n",
       "      <td>platelet aggregation inhibitor</td>\n",
       "      <td>5.84</td>\n",
       "      <td>1.152</td>\n",
       "      <td>5.84</td>\n",
       "      <td>0.0</td>\n",
       "      <td>-1.24</td>\n",
       "      <td>-6.8</td>\n",
       "      <td>6.38</td>\n",
       "      <td>...</td>\n",
       "      <td>89.79</td>\n",
       "      <td>18.87</td>\n",
       "      <td>92.50</td>\n",
       "      <td>60.36</td>\n",
       "      <td>233.58</td>\n",
       "      <td>124.85</td>\n",
       "      <td>70.51</td>\n",
       "      <td>129.96</td>\n",
       "      <td>328.46</td>\n",
       "      <td>4.550</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6371</th>\n",
       "      <td>Y-27152</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>potassium channel activator</td>\n",
       "      <td>7.22</td>\n",
       "      <td>6.301</td>\n",
       "      <td>6.32</td>\n",
       "      <td>-5.7</td>\n",
       "      <td>-5.88</td>\n",
       "      <td>-6.2</td>\n",
       "      <td>5.86</td>\n",
       "      <td>...</td>\n",
       "      <td>47.66</td>\n",
       "      <td>0.00</td>\n",
       "      <td>141.15</td>\n",
       "      <td>126.15</td>\n",
       "      <td>35.08</td>\n",
       "      <td>0.00</td>\n",
       "      <td>0.00</td>\n",
       "      <td>5.26</td>\n",
       "      <td>82.79</td>\n",
       "      <td>5.515</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6372</th>\n",
       "      <td>SR-11302</td>\n",
       "      <td>Preclinical</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6.39</td>\n",
       "      <td>5.367</td>\n",
       "      <td>6.01</td>\n",
       "      <td>-5.7</td>\n",
       "      <td>-5.89</td>\n",
       "      <td>-6.1</td>\n",
       "      <td>5.19</td>\n",
       "      <td>...</td>\n",
       "      <td>0.00</td>\n",
       "      <td>9.56</td>\n",
       "      <td>179.62</td>\n",
       "      <td>166.63</td>\n",
       "      <td>66.55</td>\n",
       "      <td>0.00</td>\n",
       "      <td>3.19</td>\n",
       "      <td>1.46</td>\n",
       "      <td>40.13</td>\n",
       "      <td>5.485</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>6373 rows × 53 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        compound_name clinical_phase  \\\n",
       "0         lersivirine        Phase 2   \n",
       "1          radafaxine        Phase 2   \n",
       "2         telcagepant        Phase 3   \n",
       "3     benzenemethanol    Preclinical   \n",
       "4        mitoxantrone       Launched   \n",
       "...               ...            ...   \n",
       "6368       clofedanol       Launched   \n",
       "6369       Debio-0932        Phase 1   \n",
       "6370     eptifibatide       Launched   \n",
       "6371          Y-27152        Phase 1   \n",
       "6372         SR-11302    Preclinical   \n",
       "\n",
       "                                 mechanism_of_action  cf_max_score  \\\n",
       "0     non-nucleoside reverse transcriptase inhibitor          6.29   \n",
       "1         dopamine-norepinephrine reuptake inhibitor          6.81   \n",
       "2                              calcitonin antagonist          6.12   \n",
       "3                                                NaN          6.78   \n",
       "4                            topoisomerase inhibitor          6.09   \n",
       "...                                              ...           ...   \n",
       "6368                   histamine receptor antagonist          6.49   \n",
       "6369                                   HSP inhibitor          6.78   \n",
       "6370                  platelet aggregation inhibitor          5.84   \n",
       "6371                     potassium channel activator          7.22   \n",
       "6372                                             NaN          6.39   \n",
       "\n",
       "      cf_avg_score  cf_top_pose  docking_max_score  docking_avg_score  \\\n",
       "0            5.747         5.87               -5.2              -5.45   \n",
       "1            5.670         5.27               -4.9              -5.08   \n",
       "2            5.429         5.04               -5.4              -5.66   \n",
       "3            5.522         5.67               -4.2              -4.49   \n",
       "4            5.593         5.88               -4.8              -4.89   \n",
       "...            ...          ...                ...                ...   \n",
       "6368         5.661         6.00               -4.9              -5.07   \n",
       "6369         5.252         4.40               -4.6              -4.74   \n",
       "6370         1.152         5.84                0.0              -1.24   \n",
       "6371         6.301         6.32               -5.7              -5.88   \n",
       "6372         5.367         6.01               -5.7              -5.89   \n",
       "\n",
       "      docking_top_pose  safety_Aurora kinase A  ...  chem_slogp_vsa3  \\\n",
       "0                 -5.6                    4.35  ...           116.25   \n",
       "1                 -5.5                    5.40  ...            20.93   \n",
       "2                 -6.1                    5.65  ...            73.76   \n",
       "3                 -4.8                    4.52  ...            18.44   \n",
       "4                 -5.2                    5.78  ...           152.49   \n",
       "...                ...                     ...  ...              ...   \n",
       "6368              -5.5                    5.51  ...            18.44   \n",
       "6369              -4.9                    5.91  ...            59.86   \n",
       "6370              -6.8                    6.38  ...            89.79   \n",
       "6371              -6.2                    5.86  ...            47.66   \n",
       "6372              -6.1                    5.19  ...             0.00   \n",
       "\n",
       "      chem_slogp_vsa5  chem_slogp_vsa7  chem_slogp_vsa9  chem_smr_vsa0  \\\n",
       "0               37.74            52.93            95.58           0.00   \n",
       "1                0.00            70.57           139.13          11.00   \n",
       "2                0.00           105.43           127.61          71.59   \n",
       "3                0.00            52.93           133.30           0.00   \n",
       "4                0.00            70.57            10.76          90.41   \n",
       "...               ...              ...              ...            ...   \n",
       "6368            65.79           158.79            39.15           3.12   \n",
       "6369            68.04            74.43           166.21          16.79   \n",
       "6370            18.87            92.50            60.36         233.58   \n",
       "6371             0.00           141.15           126.15          35.08   \n",
       "6372             9.56           179.62           166.63          66.55   \n",
       "\n",
       "      chem_smr_vsa2  chem_smr_vsa4  chem_smr_vsa6  chem_tpsa  cv_safety_score  \n",
       "0              0.00           0.00          20.93      94.86            5.670  \n",
       "1              0.00           0.00          20.93      46.07            5.695  \n",
       "2             47.14          23.10          88.68      97.88            5.770  \n",
       "3              0.00           0.00          18.44      36.84            5.125  \n",
       "4              0.00          41.53         163.87     175.17            4.895  \n",
       "...             ...            ...            ...        ...              ...  \n",
       "6368           0.00           0.00          18.44      24.67            5.500  \n",
       "6369           5.37           9.37          59.86      96.29            6.280  \n",
       "6370         124.85          70.51         129.96     328.46            4.550  \n",
       "6371           0.00           0.00           5.26      82.79            5.515  \n",
       "6372           0.00           3.19           1.46      40.13            5.485  \n",
       "\n",
       "[6373 rows x 53 columns]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_less_null"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "d9a6db6f",
   "metadata": {},
   "outputs": [],
   "source": [
    "compound_list = [\n",
    "    \"andarine\", \"AZD2461\", \"BMS-906024\", \"candesartan\", \"CPI-0610\", \"cycloheximide\",\n",
    "    \"dienogest\", \"epinastine\", \"evodiamine\", \"hypericin\", \"I-BRD9\", \"ilaprazole\",\n",
    "    \"indiplon\", \"INT-767\", \"ITX3\", \"K-strophanthidin\", \"L-701324\", \"LY2183240\",\n",
    "    \"MK-1064\", \"monensin\", \"narasin\", \"navarixin\", \"obeticholic-acid\",\n",
    "    \"olmesartan-medoxomil\", \"palmatine-chloride\", \"perfluorodecalin\",\n",
    "    \"PF-04217903\", \"PF-477736\", \"PIK-293\", \"resmetirom\", \"RU-28318\",\n",
    "    \"sanguinarium-chloride\", \"SCH-58261\", \"SP-100030\", \"SPP86\", \"sulfinpyrazone\",\n",
    "    \"sulindac\", \"TAK-063\", \"TC-S-7009\", \"TEPP-46\", \"tivantinib\"\n",
    "]\n",
    "\n",
    "data_less_null['high_potential'] = data_less_null['compound_name'].isin(compound_list).astype(int)\n",
    "\n",
    "# Display the count of high potential vs non-high potential compounds to verify\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "d30fd8ad",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "high_potential\n",
       "0    6332\n",
       "1      41\n",
       "Name: count, dtype: int64"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "data_less_null['high_potential'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "f1ab7121",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "from sklearn.model_selection import StratifiedKFold, cross_val_score\n",
    "from sklearn.ensemble import RandomForestClassifier\n",
    "from imblearn.over_sampling import SMOTE\n",
    "from imblearn.pipeline import Pipeline\n",
    "from sklearn.metrics import classification_report, confusion_matrix, accuracy_score\n",
    "\n",
    "pipeline = Pipeline([\n",
    "    ('smote', SMOTE(random_state=42)),\n",
    "    ('randomforest', RandomForestClassifier(random_state=42, n_estimators=100))\n",
    "])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "d628545b",
   "metadata": {},
   "outputs": [],
   "source": [
    "n_splits = 5 # You can adjust the number of splits\n",
    "skf = StratifiedKFold(n_splits=n_splits, shuffle=True, random_state=42)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "e6641185",
   "metadata": {},
   "outputs": [],
   "source": [
    "y = data_less_null['high_potential']\n",
    "X = data_less_null.drop(columns=['high_potential'])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3e7e5505",
   "metadata": {},
   "source": [
    "# ADA boost"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "9dd32386",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Original class distribution:\n",
      "high_potential\n",
      "0    6332\n",
      "1      41\n",
      "Name: count, dtype: int64\n",
      "------------------------------\n",
      "Numerical columns: ['cf_max_score', 'cf_avg_score', 'cf_top_pose', 'docking_max_score', 'docking_avg_score', 'docking_top_pose', 'safety_Aurora kinase A', 'safety_Bile Salt Export Pump model 2', 'safety_Caspase 3', 'safety_Cathepsin L1', 'safety_hERG_pIC50', 'safety_KCNA5', 'safety_Muscarinic acetylcholine receptor M1', 'safety_Muscarinic acetylcholine receptor M3', 'hERG_pIC50', 'KCNA5', 'pk_Human microsomal clearance model 2', 'chem_a_acc', 'chem_a_don', 'chem_chi0', 'chem_chi1', 'chem_chi0_c', 'chem_chi1_c', 'chem_kier1', 'chem_lip_acc', 'chem_npr1', 'chem_peoe_pcplus', 'chem_peoe_vsaplus0', 'chem_peoe_vsaplus2', 'chem_peoe_vsaplus4', 'chem_peoe_vsaplus6', 'chem_peoe_vsaminus1', 'chem_peoe_vsaminus3', 'chem_peoe_vsaminus5', 'chem_pmi', 'chem_pmi2', 'chem_pmix', 'chem_pmiz', 'chem_slogp', 'chem_slogp_vsa1', 'chem_slogp_vsa3', 'chem_slogp_vsa5', 'chem_slogp_vsa7', 'chem_slogp_vsa9', 'chem_smr_vsa0', 'chem_smr_vsa2', 'chem_smr_vsa4', 'chem_smr_vsa6', 'chem_tpsa', 'cv_safety_score']\n",
      "Categorical columns: ['compound_name', 'clinical_phase', 'mechanism_of_action']\n",
      "------------------------------\n",
      "Performing 5-fold stratified cross-validation with preprocessing, SMOTE, and AdaBoost...\n",
      "\n",
      "--- Fold 1/5 ---\n",
      "Training class distribution:\n",
      "high_potential\n",
      "0    5065\n",
      "1      33\n",
      "Name: count, dtype: int64\n",
      "Testing class distribution:\n",
      "high_potential\n",
      "0    1267\n",
      "1       8\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Classification Report (Fold 1):\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      1.00      1.00      1267\n",
      "           1       0.54      0.88      0.67         8\n",
      "\n",
      "    accuracy                           0.99      1275\n",
      "   macro avg       0.77      0.94      0.83      1275\n",
      "weighted avg       1.00      0.99      1.00      1275\n",
      "\n",
      "Confusion Matrix (Fold 1):\n",
      "[[1261    6]\n",
      " [   1    7]]\n",
      "Accuracy (Fold 1): 0.9945\n",
      "AUC-ROC (Fold 1): 0.9938\n",
      "\n",
      "--- Fold 2/5 ---\n",
      "Training class distribution:\n",
      "high_potential\n",
      "0    5065\n",
      "1      33\n",
      "Name: count, dtype: int64\n",
      "Testing class distribution:\n",
      "high_potential\n",
      "0    1267\n",
      "1       8\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Classification Report (Fold 2):\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      1.00      1.00      1267\n",
      "           1       1.00      1.00      1.00         8\n",
      "\n",
      "    accuracy                           1.00      1275\n",
      "   macro avg       1.00      1.00      1.00      1275\n",
      "weighted avg       1.00      1.00      1.00      1275\n",
      "\n",
      "Confusion Matrix (Fold 2):\n",
      "[[1267    0]\n",
      " [   0    8]]\n",
      "Accuracy (Fold 2): 1.0000\n",
      "AUC-ROC (Fold 2): 1.0000\n",
      "\n",
      "--- Fold 3/5 ---\n",
      "Training class distribution:\n",
      "high_potential\n",
      "0    5066\n",
      "1      32\n",
      "Name: count, dtype: int64\n",
      "Testing class distribution:\n",
      "high_potential\n",
      "0    1266\n",
      "1       9\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Classification Report (Fold 3):\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      1.00      1.00      1266\n",
      "           1       0.67      0.67      0.67         9\n",
      "\n",
      "    accuracy                           1.00      1275\n",
      "   macro avg       0.83      0.83      0.83      1275\n",
      "weighted avg       1.00      1.00      1.00      1275\n",
      "\n",
      "Confusion Matrix (Fold 3):\n",
      "[[1263    3]\n",
      " [   3    6]]\n",
      "Accuracy (Fold 3): 0.9953\n",
      "AUC-ROC (Fold 3): 0.9965\n",
      "\n",
      "--- Fold 4/5 ---\n",
      "Training class distribution:\n",
      "high_potential\n",
      "0    5066\n",
      "1      33\n",
      "Name: count, dtype: int64\n",
      "Testing class distribution:\n",
      "high_potential\n",
      "0    1266\n",
      "1       8\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Classification Report (Fold 4):\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      0.99      0.99      1266\n",
      "           1       0.35      0.88      0.50         8\n",
      "\n",
      "    accuracy                           0.99      1274\n",
      "   macro avg       0.67      0.93      0.75      1274\n",
      "weighted avg       1.00      0.99      0.99      1274\n",
      "\n",
      "Confusion Matrix (Fold 4):\n",
      "[[1253   13]\n",
      " [   1    7]]\n",
      "Accuracy (Fold 4): 0.9890\n",
      "AUC-ROC (Fold 4): 0.9967\n",
      "\n",
      "--- Fold 5/5 ---\n",
      "Training class distribution:\n",
      "high_potential\n",
      "0    5066\n",
      "1      33\n",
      "Name: count, dtype: int64\n",
      "Testing class distribution:\n",
      "high_potential\n",
      "0    1266\n",
      "1       8\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Classification Report (Fold 5):\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      0.99      1.00      1266\n",
      "           1       0.33      0.50      0.40         8\n",
      "\n",
      "    accuracy                           0.99      1274\n",
      "   macro avg       0.67      0.75      0.70      1274\n",
      "weighted avg       0.99      0.99      0.99      1274\n",
      "\n",
      "Confusion Matrix (Fold 5):\n",
      "[[1258    8]\n",
      " [   4    4]]\n",
      "Accuracy (Fold 5): 0.9906\n",
      "AUC-ROC (Fold 5): 0.9807\n",
      "\n",
      "==============================\n",
      "Overall Performance Across All Folds:\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      1.00      1.00      6332\n",
      "           1       0.52      0.78      0.62        41\n",
      "\n",
      "    accuracy                           0.99      6373\n",
      "   macro avg       0.76      0.89      0.81      6373\n",
      "weighted avg       1.00      0.99      0.99      6373\n",
      "\n",
      "Confusion Matrix (Overall):\n",
      "[[6302   30]\n",
      " [   9   32]]\n",
      "Overall Accuracy: 0.9939\n",
      "Overall AUC-ROC: 0.9935\n",
      "Overall F1-Score (Minority Class 1): 0.6214\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "from sklearn.model_selection import StratifiedKFold\n",
    "from sklearn.ensemble import AdaBoostClassifier\n",
    "from sklearn.tree import DecisionTreeClassifier\n",
    "from imblearn.over_sampling import SMOTE\n",
    "from imblearn.pipeline import Pipeline\n",
    "from sklearn.metrics import classification_report, confusion_matrix, accuracy_score, roc_auc_score, f1_score\n",
    "from sklearn.compose import ColumnTransformer\n",
    "from sklearn.preprocessing import OneHotEncoder, StandardScaler\n",
    "from sklearn.impute import SimpleImputer\n",
    "print(\"Original class distribution:\")\n",
    "print(y.value_counts())\n",
    "print(\"-\" * 30)\n",
    "\n",
    "# --- 2. Identify Column Types ---\n",
    "# Use .columns to get column names for select_dtypes\n",
    "numerical_cols = X.select_dtypes(include=['number']).columns.tolist()\n",
    "categorical_cols = X.select_dtypes(include=['object', 'category']).columns.tolist()\n",
    "\n",
    "print(f\"Numerical columns: {numerical_cols}\")\n",
    "print(f\"Categorical columns: {categorical_cols}\")\n",
    "print(\"-\" * 30)\n",
    "\n",
    "# --- 3. Create Preprocessing Steps (ColumnTransformer) ---\n",
    "# Preprocessing for numerical features: impute missing values then scale\n",
    "numerical_transformer = Pipeline(steps=[\n",
    "    ('imputer', SimpleImputer(strategy='mean')), # 'mean', 'median', or 'most_frequent'\n",
    "    ('scaler', StandardScaler())\n",
    "])\n",
    "\n",
    "# Preprocessing for categorical features: impute missing values then one-hot encode\n",
    "categorical_transformer = Pipeline(steps=[\n",
    "    ('imputer', SimpleImputer(strategy='most_frequent')), # For categorical, 'most_frequent'\n",
    "    ('onehot', OneHotEncoder(handle_unknown='ignore')) # handle_unknown='ignore' is crucial\n",
    "])\n",
    "\n",
    "# Create a preprocessor using ColumnTransformer\n",
    "preprocessor = ColumnTransformer(\n",
    "    transformers=[\n",
    "        ('num', numerical_transformer, numerical_cols),\n",
    "        ('cat', categorical_transformer, categorical_cols)\n",
    "    ],\n",
    "    remainder='passthrough' # Keep any other columns not specified (if any)\n",
    ")\n",
    "\n",
    "# --- 4. Define the Model and Pipeline ---\n",
    "# Define the base estimator for AdaBoost (DecisionTreeClassifier is standard)\n",
    "# Using max_depth=1 (a decision stump) is common and often effective for AdaBoost.\n",
    "base_estimator = DecisionTreeClassifier(max_depth=1, random_state=42)\n",
    "\n",
    "# Use imblearn's Pipeline to integrate preprocessor, SMOTE, and AdaBoost\n",
    "pipeline = Pipeline(steps=[\n",
    "    ('preprocessor', preprocessor), # Apply preprocessing first\n",
    "    ('smote', SMOTE(random_state=42)), # Oversample the minority class\n",
    "    ('adaboost', AdaBoostClassifier(estimator=base_estimator, n_estimators=100, random_state=42))\n",
    "    # n_estimators is the number of boosting stages (weak learners)\n",
    "    # You can tune n_estimators and learning_rate\n",
    "])\n",
    "\n",
    "# --- 5. Set up Cross-Validation ---\n",
    "n_splits = 5 # You can adjust the number of splits (e.g., 5 or 10)\n",
    "skf = StratifiedKFold(n_splits=n_splits, shuffle=True, random_state=42)\n",
    "\n",
    "# --- 6. Perform Cross-Validation ---\n",
    "print(f\"Performing {n_splits}-fold stratified cross-validation with preprocessing, SMOTE, and AdaBoost...\")\n",
    "\n",
    "all_y_true = []\n",
    "all_y_pred = []\n",
    "all_y_proba = [] # To store probabilities for AUC calculation\n",
    "\n",
    "for fold, (train_index, test_index) in enumerate(skf.split(X, y)):\n",
    "    X_train, X_test = X.iloc[train_index], X.iloc[test_index]\n",
    "    y_train, y_test = y.iloc[train_index], y.iloc[test_index]\n",
    "\n",
    "    print(f\"\\n--- Fold {fold+1}/{n_splits} ---\")\n",
    "    print(\"Training class distribution:\")\n",
    "    print(y_train.value_counts())\n",
    "    print(\"Testing class distribution:\")\n",
    "    print(y_test.value_counts())\n",
    "\n",
    "    # Fit the pipeline on the training data\n",
    "    # Preprocessing, SMOTE, and AdaBoost will be applied sequentially.\n",
    "    pipeline.fit(X_train, y_train)\n",
    "\n",
    "    # Make predictions on the test set\n",
    "    y_pred = pipeline.predict(X_test)\n",
    "    y_proba = pipeline.predict_proba(X_test)[:, 1] # Probability of the positive class (1)\n",
    "\n",
    "    # Collect true and predicted values for overall report\n",
    "    all_y_true.extend(y_test)\n",
    "    all_y_pred.extend(y_pred)\n",
    "    all_y_proba.extend(y_proba)\n",
    "\n",
    "    # Evaluate the model for the current fold\n",
    "    print(\"\\nClassification Report (Fold {}):\".format(fold+1))\n",
    "    print(classification_report(y_test, y_pred, zero_division=0)) # zero_division=0 to avoid warning if no predictions for a class\n",
    "    print(\"Confusion Matrix (Fold {}):\".format(fold+1))\n",
    "    print(confusion_matrix(y_test, y_pred))\n",
    "    print(\"Accuracy (Fold {}): {:.4f}\".format(fold+1, accuracy_score(y_test, y_pred)))\n",
    "    # Calculate AUC-ROC for this fold\n",
    "    try:\n",
    "        auc_roc = roc_auc_score(y_test, y_proba)\n",
    "        print(\"AUC-ROC (Fold {}): {:.4f}\".format(fold+1, auc_roc))\n",
    "    except ValueError:\n",
    "        print(\"AUC-ROC (Fold {}): Not applicable (only one class present in y_true_proba)\".format(fold+1))\n",
    "\n",
    "\n",
    "# --- 7. Overall Evaluation (Aggregated across all folds) ---\n",
    "print(\"\\n\" + \"=\" * 30)\n",
    "print(\"Overall Performance Across All Folds:\")\n",
    "print(classification_report(all_y_true, all_y_pred, zero_division=0))\n",
    "print(\"Confusion Matrix (Overall):\")\n",
    "print(confusion_matrix(all_y_true, all_y_pred))\n",
    "print(\"Overall Accuracy: {:.4f}\".format(accuracy_score(all_y_true, all_y_pred)))\n",
    "\n",
    "# Calculate overall AUC-ROC\n",
    "try:\n",
    "    overall_auc_roc = roc_auc_score(all_y_true, all_y_proba)\n",
    "    print(\"Overall AUC-ROC: {:.4f}\".format(overall_auc_roc))\n",
    "except ValueError:\n",
    "    print(\"Overall AUC-ROC: Not applicable (only one class present in overall y_true_proba)\")\n",
    "\n",
    "# Additionally, calculate overall F1-score for the minority class (class 1)\n",
    "# Note: For highly imbalanced data, macro or weighted F1 might be more indicative\n",
    "# than micro, but here we explicitly look at the minority class.\n",
    "overall_f1_minority = f1_score(all_y_true, all_y_pred, pos_label=1, zero_division=0)\n",
    "print(f\"Overall F1-Score (Minority Class 1): {overall_f1_minority:.4f}\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "d964012d",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Original class distribution:\n",
      "high_potential\n",
      "0    6332\n",
      "1      41\n",
      "Name: count, dtype: int64\n",
      "------------------------------\n",
      "------------------------------\n",
      "Training final model on full dataset to extract feature importances...\n",
      "\n",
      "Top 20 Feature Importances (AdaBoost Model):\n",
      "                                             Feature  Importance\n",
      "0                                  num__cf_max_score    0.159693\n",
      "6                        num__safety_Aurora kinase A    0.083179\n",
      "10                            num__safety_hERG_pIC50    0.077217\n",
      "4                             num__docking_avg_score    0.072923\n",
      "3                             num__docking_max_score    0.061487\n",
      "11                                 num__safety_KCNA5    0.044557\n",
      "15                                        num__KCNA5    0.041856\n",
      "6380                 cat__clinical_phase_Preclinical    0.040213\n",
      "6377                     cat__clinical_phase_Phase 2    0.029973\n",
      "47                                num__chem_smr_vsa6    0.029861\n",
      "5                              num__docking_top_pose    0.028060\n",
      "8                              num__safety_Caspase 3    0.026556\n",
      "4242                   cat__compound_name_ilaprazole    0.022876\n",
      "399                       cat__compound_name_AZD2461    0.018592\n",
      "18                                   num__chem_a_don    0.018387\n",
      "29                           num__chem_peoe_vsaplus4    0.018170\n",
      "46                                num__chem_smr_vsa4    0.017366\n",
      "6951  cat__mechanism_of_action_bromodomain inhibitor    0.014675\n",
      "1387                      cat__compound_name_MK-1064    0.014591\n",
      "39                              num__chem_slogp_vsa1    0.014330\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- Summed Importance for Original Categorical Features ---\n",
      "Total Importance for 'compound_name': 0.1339\n",
      "Total Importance for 'clinical_phase': 0.0702\n",
      "Total Importance for 'mechanism_of_action': 0.0319\n"
     ]
    }
   ],
   "source": [
    "\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "from sklearn.model_selection import StratifiedKFold\n",
    "from sklearn.ensemble import AdaBoostClassifier\n",
    "from sklearn.tree import DecisionTreeClassifier\n",
    "from imblearn.over_sampling import SMOTE\n",
    "from imblearn.pipeline import Pipeline\n",
    "from sklearn.metrics import classification_report, confusion_matrix, accuracy_score, roc_auc_score, f1_score\n",
    "from sklearn.compose import ColumnTransformer\n",
    "from sklearn.preprocessing import OneHotEncoder, StandardScaler\n",
    "from sklearn.impute import SimpleImputer\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "y = data_less_null['high_potential']\n",
    "X = data_less_null.drop(columns=['high_potential'])\n",
    "\n",
    "print(\"Original class distribution:\")\n",
    "print(y.value_counts())\n",
    "print(\"-\" * 30)\n",
    "\n",
    "# --- 2. Identify Column Types (using your actual column names as provided) ---\n",
    "numerical_cols = ['cf_max_score', 'cf_avg_score', 'cf_top_pose', 'docking_max_score', 'docking_avg_score', 'docking_top_pose', 'safety_Aurora kinase A', 'safety_Bile Salt Export Pump model 2', 'safety_Caspase 3', 'safety_Cathepsin L1', 'safety_hERG_pIC50', 'safety_KCNA5', 'safety_Muscarinic acetylcholine receptor M1', 'safety_Muscarinic acetylcholine receptor M3', 'hERG_pIC50', 'KCNA5', 'pk_Human microsomal clearance model 2', 'chem_a_acc', 'chem_a_don', 'chem_chi0', 'chem_chi1', 'chem_chi0_c', 'chem_chi1_c', 'chem_kier1', 'chem_lip_acc', 'chem_npr1', 'chem_peoe_pcplus', 'chem_peoe_vsaplus0', 'chem_peoe_vsaplus2', 'chem_peoe_vsaplus4', 'chem_peoe_vsaplus6', 'chem_peoe_vsaminus1', 'chem_peoe_vsaminus3', 'chem_peoe_vsaminus5', 'chem_pmi', 'chem_pmi2', 'chem_pmix', 'chem_pmiz', 'chem_slogp', 'chem_slogp_vsa1', 'chem_slogp_vsa3', 'chem_slogp_vsa5', 'chem_slogp_vsa7', 'chem_slogp_vsa9', 'chem_smr_vsa0', 'chem_smr_vsa2', 'chem_smr_vsa4', 'chem_smr_vsa6', 'chem_tpsa', 'cv_safety_score']\n",
    "categorical_cols = ['compound_name', 'clinical_phase', 'mechanism_of_action']\n",
    "\n",
    "# A quick check for robust column identification in case of slight mismatches\n",
    "# (useful if you ran dummy data generation previously and now use real data)\n",
    "if not set(numerical_cols).issubset(X.columns) or not set(categorical_cols).issubset(X.columns):\n",
    "    print(\"\\nWarning: Provided numerical/categorical column lists do not perfectly match X.columns.\")\n",
    "    print(\"Re-identifying columns based on DataFrame dtypes.\")\n",
    "    numerical_cols = X.select_dtypes(include=np.number).columns.tolist()\n",
    "    categorical_cols = X.select_dtypes(include=['object', 'category']).columns.tolist()\n",
    "    print(f\"Re-identified Numerical columns: {numerical_cols}\")\n",
    "    print(f\"Re-identified Categorical columns: {categorical_cols}\")\n",
    "\n",
    "print(\"-\" * 30)\n",
    "\n",
    "# --- 3. Create Preprocessing Steps (ColumnTransformer) ---\n",
    "numerical_transformer = Pipeline(steps=[\n",
    "    ('imputer', SimpleImputer(strategy='mean')),\n",
    "    ('scaler', StandardScaler())\n",
    "])\n",
    "\n",
    "categorical_transformer = Pipeline(steps=[\n",
    "    ('imputer', SimpleImputer(strategy='most_frequent')),\n",
    "    ('onehot', OneHotEncoder(handle_unknown='ignore'))\n",
    "])\n",
    "\n",
    "preprocessor = ColumnTransformer(\n",
    "    transformers=[\n",
    "        ('num', numerical_transformer, numerical_cols),\n",
    "        ('cat', categorical_transformer, categorical_cols)\n",
    "    ],\n",
    "    remainder='passthrough'\n",
    ")\n",
    "\n",
    "# --- 4. Define the Model and Pipeline ---\n",
    "base_estimator = DecisionTreeClassifier(max_depth=1, random_state=42)\n",
    "\n",
    "pipeline = Pipeline(steps=[\n",
    "    ('preprocessor', preprocessor),\n",
    "    ('smote', SMOTE(random_state=42)),\n",
    "    ('adaboost', AdaBoostClassifier(estimator=base_estimator, n_estimators=100, random_state=42))\n",
    "])\n",
    "\n",
    "# --- 5. Train the pipeline on the full dataset to get feature importances ---\n",
    "# It's important to train on the full data AFTER cross-validation\n",
    "# to get a single, final model for feature importance.\n",
    "print(\"Training final model on full dataset to extract feature importances...\")\n",
    "pipeline.fit(X, y)\n",
    "\n",
    "# --- 6. Extract Feature Importances ---\n",
    "\n",
    "# Access the AdaBoost model from the pipeline\n",
    "adaboost_model = pipeline.named_steps['adaboost']\n",
    "\n",
    "# Get feature importances\n",
    "importances = adaboost_model.feature_importances_\n",
    "\n",
    "# Get feature names after preprocessing using .get_feature_names_out()\n",
    "try:\n",
    "    feature_names_out = pipeline.named_steps['preprocessor'].get_feature_names_out()\n",
    "except AttributeError:\n",
    "    # Fallback for older scikit-learn versions (<1.0) or if method is not available\n",
    "    # This manual reconstruction is more complex and might not cover all edge cases\n",
    "    # (e.g., remainder='passthrough' columns not explicitly in numerical_cols)\n",
    "    print(\"Warning: .get_feature_names_out() not found for preprocessor. Falling back to manual inference.\")\n",
    "    \n",
    "    transformed_numerical_features = numerical_cols\n",
    "    \n",
    "    # Get one-hot encoded feature names\n",
    "    ohe = pipeline.named_steps['preprocessor'].named_transformers_['cat'].named_steps['onehot']\n",
    "    # Ensure categorical_cols used here are the original ones fed to OHE\n",
    "    ohe_feature_names = ohe.get_feature_names_out(categorical_cols)\n",
    "    \n",
    "    # Combine numerical and one-hot encoded names.\n",
    "    # If remainder='passthrough' was active and there were other columns, they'd need to be added.\n",
    "    # For this specific setup, they are either numerical or categorical.\n",
    "    feature_names_out = transformed_numerical_features + list(ohe_feature_names)\n",
    "\n",
    "\n",
    "# Create a DataFrame for better visualization\n",
    "feature_importance_df = pd.DataFrame({\n",
    "    'Feature': feature_names_out,\n",
    "    'Importance': importances\n",
    "})\n",
    "\n",
    "# Sort by importance\n",
    "feature_importance_df = feature_importance_df.sort_values(by='Importance', ascending=False)\n",
    "\n",
    "# --- 7. Display and Plot Feature Importances ---\n",
    "print(\"\\nTop 20 Feature Importances (AdaBoost Model):\")\n",
    "print(feature_importance_df.head(20))\n",
    "\n",
    "plt.figure(figsize=(12, 8))\n",
    "sns.barplot(x='Importance', y='Feature', data=feature_importance_df.head(20))\n",
    "plt.title('Top 20 Feature Importances (AdaBoost)')\n",
    "plt.xlabel('Importance')\n",
    "plt.ylabel('Feature Name')\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# --- Optional: Sum importance for original categorical features ---\n",
    "print(\"\\n--- Summed Importance for Original Categorical Features ---\")\n",
    "for cat_col in categorical_cols:\n",
    "    # Filter for features that belong to this original categorical column\n",
    "    # They will be named like 'cat__original_col_category_value'\n",
    "    relevant_importances = feature_importance_df[\n",
    "        feature_importance_df['Feature'].str.startswith(f'cat__{cat_col}_')\n",
    "    ]\n",
    "    if not relevant_importances.empty:\n",
    "        print(f\"Total Importance for '{cat_col}': {relevant_importances['Importance'].sum():.4f}\")\n",
    "    else:\n",
    "        print(f\"No one-hot encoded features found for '{cat_col}'.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "41ac11b2",
   "metadata": {},
   "source": [
    "# gradeitn boost"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "99e5c779",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Original class distribution:\n",
      "high_potential\n",
      "0    6332\n",
      "1      41\n",
      "Name: count, dtype: int64\n",
      "------------------------------\n",
      "------------------------------\n",
      "Performing 5-fold stratified cross-validation with preprocessing, SMOTE, and Gradient Boosting...\n",
      "\n",
      "--- Fold 1/5 ---\n",
      "Training class distribution:\n",
      "high_potential\n",
      "0    5065\n",
      "1      33\n",
      "Name: count, dtype: int64\n",
      "Testing class distribution:\n",
      "high_potential\n",
      "0    1267\n",
      "1       8\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Classification Report (Fold 1):\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      0.99      0.99      1267\n",
      "           1       0.30      0.88      0.45         8\n",
      "\n",
      "    accuracy                           0.99      1275\n",
      "   macro avg       0.65      0.93      0.72      1275\n",
      "weighted avg       0.99      0.99      0.99      1275\n",
      "\n",
      "Confusion Matrix (Fold 1):\n",
      "[[1251   16]\n",
      " [   1    7]]\n",
      "Accuracy (Fold 1): 0.9867\n",
      "AUC-ROC (Fold 1): 0.9952\n",
      "\n",
      "--- Fold 2/5 ---\n",
      "Training class distribution:\n",
      "high_potential\n",
      "0    5065\n",
      "1      33\n",
      "Name: count, dtype: int64\n",
      "Testing class distribution:\n",
      "high_potential\n",
      "0    1267\n",
      "1       8\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Classification Report (Fold 2):\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      0.99      1.00      1267\n",
      "           1       0.42      1.00      0.59         8\n",
      "\n",
      "    accuracy                           0.99      1275\n",
      "   macro avg       0.71      1.00      0.79      1275\n",
      "weighted avg       1.00      0.99      0.99      1275\n",
      "\n",
      "Confusion Matrix (Fold 2):\n",
      "[[1256   11]\n",
      " [   0    8]]\n",
      "Accuracy (Fold 2): 0.9914\n",
      "AUC-ROC (Fold 2): 0.9980\n",
      "\n",
      "--- Fold 3/5 ---\n",
      "Training class distribution:\n",
      "high_potential\n",
      "0    5066\n",
      "1      32\n",
      "Name: count, dtype: int64\n",
      "Testing class distribution:\n",
      "high_potential\n",
      "0    1266\n",
      "1       9\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Classification Report (Fold 3):\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      0.98      0.99      1266\n",
      "           1       0.22      0.67      0.33         9\n",
      "\n",
      "    accuracy                           0.98      1275\n",
      "   macro avg       0.61      0.83      0.66      1275\n",
      "weighted avg       0.99      0.98      0.99      1275\n",
      "\n",
      "Confusion Matrix (Fold 3):\n",
      "[[1245   21]\n",
      " [   3    6]]\n",
      "Accuracy (Fold 3): 0.9812\n",
      "AUC-ROC (Fold 3): 0.9912\n",
      "\n",
      "--- Fold 4/5 ---\n",
      "Training class distribution:\n",
      "high_potential\n",
      "0    5066\n",
      "1      33\n",
      "Name: count, dtype: int64\n",
      "Testing class distribution:\n",
      "high_potential\n",
      "0    1266\n",
      "1       8\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Classification Report (Fold 4):\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      0.98      0.99      1266\n",
      "           1       0.22      1.00      0.36         8\n",
      "\n",
      "    accuracy                           0.98      1274\n",
      "   macro avg       0.61      0.99      0.67      1274\n",
      "weighted avg       1.00      0.98      0.98      1274\n",
      "\n",
      "Confusion Matrix (Fold 4):\n",
      "[[1237   29]\n",
      " [   0    8]]\n",
      "Accuracy (Fold 4): 0.9772\n",
      "AUC-ROC (Fold 4): 0.9971\n",
      "\n",
      "--- Fold 5/5 ---\n",
      "Training class distribution:\n",
      "high_potential\n",
      "0    5066\n",
      "1      33\n",
      "Name: count, dtype: int64\n",
      "Testing class distribution:\n",
      "high_potential\n",
      "0    1266\n",
      "1       8\n",
      "Name: count, dtype: int64\n",
      "\n",
      "Classification Report (Fold 5):\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      0.98      0.99      1266\n",
      "           1       0.20      0.62      0.30         8\n",
      "\n",
      "    accuracy                           0.98      1274\n",
      "   macro avg       0.60      0.80      0.65      1274\n",
      "weighted avg       0.99      0.98      0.99      1274\n",
      "\n",
      "Confusion Matrix (Fold 5):\n",
      "[[1246   20]\n",
      " [   3    5]]\n",
      "Accuracy (Fold 5): 0.9819\n",
      "AUC-ROC (Fold 5): 0.9646\n",
      "\n",
      "==============================\n",
      "Overall Performance Across All Folds:\n",
      "              precision    recall  f1-score   support\n",
      "\n",
      "           0       1.00      0.98      0.99      6332\n",
      "           1       0.26      0.83      0.40        41\n",
      "\n",
      "    accuracy                           0.98      6373\n",
      "   macro avg       0.63      0.91      0.69      6373\n",
      "weighted avg       0.99      0.98      0.99      6373\n",
      "\n",
      "Confusion Matrix (Overall):\n",
      "[[6235   97]\n",
      " [   7   34]]\n",
      "Overall Accuracy: 0.9837\n",
      "Overall AUC-ROC: 0.9891\n",
      "Overall F1-Score (Minority Class 1): 0.3953\n",
      "\n",
      "==============================\n",
      "Extracting Feature Importances for Gradient Boosting Model...\n",
      "\n",
      "Top 20 Feature Importances (Gradient Boosting Model):\n",
      "                                                Feature  Importance\n",
      "0                                     num__cf_max_score    0.763307\n",
      "4                                num__docking_avg_score    0.131063\n",
      "47                                   num__chem_smr_vsa6    0.013650\n",
      "3                                num__docking_max_score    0.013105\n",
      "6                           num__safety_Aurora kinase A    0.012111\n",
      "11                                    num__safety_KCNA5    0.012003\n",
      "14                                      num__hERG_pIC50    0.007855\n",
      "10                               num__safety_hERG_pIC50    0.007597\n",
      "8                                 num__safety_Caspase 3    0.007402\n",
      "15                                           num__KCNA5    0.006727\n",
      "4203                       cat__compound_name_hypericin    0.002580\n",
      "5                                 num__docking_top_pose    0.002394\n",
      "7126  cat__mechanism_of_action_dopamine synthesis in...    0.002323\n",
      "5103              cat__compound_name_palmatine-chloride    0.002137\n",
      "25                                       num__chem_npr1    0.001683\n",
      "44                                   num__chem_smr_vsa0    0.001348\n",
      "7             num__safety_Bile Salt Export Pump model 2    0.001165\n",
      "7573  cat__mechanism_of_action_pyruvate kinase isozy...    0.001143\n",
      "49                                 num__cv_safety_score    0.000876\n",
      "7193  cat__mechanism_of_action_glucocorticoid recept...    0.000668\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x800 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- Summed Importance for Original Categorical Features ---\n",
      "Total Importance for 'compound_name': 0.0102\n",
      "Total Importance for 'clinical_phase': 0.0003\n",
      "Total Importance for 'mechanism_of_action': 0.0052\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "from sklearn.model_selection import StratifiedKFold\n",
    "from sklearn.ensemble import GradientBoostingClassifier # Changed from AdaBoostClassifier\n",
    "from sklearn.tree import DecisionTreeClassifier\n",
    "from imblearn.over_sampling import SMOTE\n",
    "from imblearn.pipeline import Pipeline\n",
    "from sklearn.metrics import classification_report, confusion_matrix, accuracy_score, roc_auc_score, f1_score\n",
    "from sklearn.compose import ColumnTransformer\n",
    "from sklearn.preprocessing import OneHotEncoder, StandardScaler\n",
    "from sklearn.impute import SimpleImputer\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "y = data_less_null['high_potential']\n",
    "X = data_less_null.drop(columns=['high_potential'])\n",
    "\n",
    "print(\"Original class distribution:\")\n",
    "print(y.value_counts())\n",
    "print(\"-\" * 30)\n",
    "\n",
    "# --- 2. Identify Column Types (using your actual column names from problem description) ---\n",
    "# Ensure these lists accurately reflect the columns in your X DataFrame\n",
    "numerical_cols = ['cf_max_score', 'cf_avg_score', 'cf_top_pose', 'docking_max_score', 'docking_avg_score', 'docking_top_pose', 'safety_Aurora kinase A', 'safety_Bile Salt Export Pump model 2', 'safety_Caspase 3', 'safety_Cathepsin L1', 'safety_hERG_pIC50', 'safety_KCNA5', 'safety_Muscarinic acetylcholine receptor M1', 'safety_Muscarinic acetylcholine receptor M3', 'hERG_pIC50', 'KCNA5', 'pk_Human microsomal clearance model 2', 'chem_a_acc', 'chem_a_don', 'chem_chi0', 'chem_chi1', 'chem_chi0_c', 'chem_chi1_c', 'chem_kier1', 'chem_lip_acc', 'chem_npr1', 'chem_peoe_pcplus', 'chem_peoe_vsaplus0', 'chem_peoe_vsaplus2', 'chem_peoe_vsaplus4', 'chem_peoe_vsaplus6', 'chem_peoe_vsaminus1', 'chem_peoe_vsaminus3', 'chem_peoe_vsaminus5', 'chem_pmi', 'chem_pmi2', 'chem_pmix', 'chem_pmiz', 'chem_slogp', 'chem_slogp_vsa1', 'chem_slogp_vsa3', 'chem_slogp_vsa5', 'chem_slogp_vsa7', 'chem_slogp_vsa9', 'chem_smr_vsa0', 'chem_smr_vsa2', 'chem_smr_vsa4', 'chem_smr_vsa6', 'chem_tpsa', 'cv_safety_score']\n",
    "categorical_cols = ['compound_name', 'clinical_phase', 'mechanism_of_action']\n",
    "\n",
    "# Robust check: If any columns are missing from X, adjust the lists\n",
    "# This is crucial if your actual data_less_null doesn't have all these columns.\n",
    "existing_numerical_cols = [col for col in numerical_cols if col in X.columns]\n",
    "missing_numerical_cols = [col for col in numerical_cols if col not in X.columns]\n",
    "if missing_numerical_cols:\n",
    "    print(f\"Warning: Numerical columns not found in X: {missing_numerical_cols}\")\n",
    "numerical_cols = existing_numerical_cols\n",
    "\n",
    "existing_categorical_cols = [col for col in categorical_cols if col in X.columns]\n",
    "missing_categorical_cols = [col for col in categorical_cols if col not in X.columns]\n",
    "if missing_categorical_cols:\n",
    "    print(f\"Warning: Categorical columns not found in X: {missing_categorical_cols}\")\n",
    "categorical_cols = existing_categorical_cols\n",
    "\n",
    "if not numerical_cols and not categorical_cols:\n",
    "    print(\"Error: No numerical or categorical columns identified from your lists. Auto-detecting columns.\")\n",
    "    numerical_cols = X.select_dtypes(include=np.number).columns.tolist()\n",
    "    categorical_cols = X.select_dtypes(include=['object', 'category']).columns.tolist()\n",
    "    print(f\"Auto-detected Numerical columns: {numerical_cols}\")\n",
    "    print(f\"Auto-detected Categorical columns: {categorical_cols}\")\n",
    "\n",
    "\n",
    "print(\"-\" * 30)\n",
    "\n",
    "# --- 3. Create Preprocessing Steps (ColumnTransformer) ---\n",
    "numerical_transformer = Pipeline(steps=[\n",
    "    ('imputer', SimpleImputer(strategy='mean')),\n",
    "    ('scaler', StandardScaler())\n",
    "])\n",
    "\n",
    "categorical_transformer = Pipeline(steps=[\n",
    "    ('imputer', SimpleImputer(strategy='most_frequent')),\n",
    "    ('onehot', OneHotEncoder(handle_unknown='ignore'))\n",
    "])\n",
    "\n",
    "preprocessor = ColumnTransformer(\n",
    "    transformers=[\n",
    "        ('num', numerical_transformer, numerical_cols),\n",
    "        ('cat', categorical_transformer, categorical_cols)\n",
    "    ],\n",
    "    remainder='passthrough'\n",
    ")\n",
    "\n",
    "# --- 4. Define the Model and Pipeline ---\n",
    "# Use GradientBoostingClassifier this time\n",
    "pipeline = Pipeline(steps=[\n",
    "    ('preprocessor', preprocessor),\n",
    "    ('smote', SMOTE(random_state=42)),\n",
    "    ('gradientboost', GradientBoostingClassifier(n_estimators=100, learning_rate=0.1, max_depth=3, random_state=42))\n",
    "    # n_estimators: Number of boosting stages\n",
    "    # learning_rate: Shrinks the contribution of each tree\n",
    "    # max_depth: Limits the depth of each individual tree (often kept small for GB)\n",
    "])\n",
    "\n",
    "# --- 5. Set up Cross-Validation ---\n",
    "n_splits = 5\n",
    "skf = StratifiedKFold(n_splits=n_splits, shuffle=True, random_state=42)\n",
    "\n",
    "# --- 6. Perform Cross-Validation (Training and Predicting) ---\n",
    "print(f\"Performing {n_splits}-fold stratified cross-validation with preprocessing, SMOTE, and Gradient Boosting...\")\n",
    "\n",
    "all_y_true = []\n",
    "all_y_pred = []\n",
    "all_y_proba = []\n",
    "\n",
    "for fold, (train_index, test_index) in enumerate(skf.split(X, y)):\n",
    "    X_train, X_test = X.iloc[train_index], X.iloc[test_index]\n",
    "    y_train, y_test = y.iloc[train_index], y.iloc[test_index]\n",
    "\n",
    "    print(f\"\\n--- Fold {fold+1}/{n_splits} ---\")\n",
    "    print(\"Training class distribution:\")\n",
    "    print(y_train.value_counts())\n",
    "    print(\"Testing class distribution:\")\n",
    "    print(y_test.value_counts())\n",
    "\n",
    "    pipeline.fit(X_train, y_train)\n",
    "\n",
    "    y_pred = pipeline.predict(X_test)\n",
    "    y_proba = pipeline.predict_proba(X_test)[:, 1]\n",
    "\n",
    "    all_y_true.extend(y_test)\n",
    "    all_y_pred.extend(y_pred)\n",
    "    all_y_proba.extend(y_proba)\n",
    "\n",
    "    print(\"\\nClassification Report (Fold {}):\".format(fold+1))\n",
    "    print(classification_report(y_test, y_pred, zero_division=0))\n",
    "    print(\"Confusion Matrix (Fold {}):\".format(fold+1))\n",
    "    print(confusion_matrix(y_test, y_pred))\n",
    "    print(\"Accuracy (Fold {}): {:.4f}\".format(fold+1, accuracy_score(y_test, y_pred)))\n",
    "    try:\n",
    "        auc_roc = roc_auc_score(y_test, y_proba)\n",
    "        print(\"AUC-ROC (Fold {}): {:.4f}\".format(fold+1, auc_roc))\n",
    "    except ValueError:\n",
    "        print(\"AUC-ROC (Fold {}): Not applicable (only one class present in y_true_proba)\".format(fold+1))\n",
    "\n",
    "# --- 7. Overall Evaluation (Aggregated across all folds) ---\n",
    "print(\"\\n\" + \"=\" * 30)\n",
    "print(\"Overall Performance Across All Folds:\")\n",
    "print(classification_report(all_y_true, all_y_pred, zero_division=0))\n",
    "print(\"Confusion Matrix (Overall):\")\n",
    "print(confusion_matrix(all_y_true, all_y_pred))\n",
    "print(\"Overall Accuracy: {:.4f}\".format(accuracy_score(all_y_true, all_y_pred)))\n",
    "try:\n",
    "    overall_auc_roc = roc_auc_score(all_y_true, all_y_proba)\n",
    "    print(\"Overall AUC-ROC: {:.4f}\".format(overall_auc_roc))\n",
    "except ValueError:\n",
    "    print(\"Overall AUC-ROC: Not applicable (only one class present in overall y_true_proba)\")\n",
    "overall_f1_minority = f1_score(all_y_true, all_y_pred, pos_label=1, zero_division=0)\n",
    "print(f\"Overall F1-Score (Minority Class 1): {overall_f1_minority:.4f}\")\n",
    "\n",
    "# --- 8. Feature Importance for the Gradient Boosting Model ---\n",
    "print(\"\\n\" + \"=\" * 30)\n",
    "print(\"Extracting Feature Importances for Gradient Boosting Model...\")\n",
    "\n",
    "# Train the pipeline on the full dataset one more time to get the final model's importances\n",
    "# This is typically done after selecting hyperparameters based on CV results.\n",
    "pipeline.fit(X, y)\n",
    "\n",
    "# Access the GradientBoostingClassifier model from the pipeline\n",
    "gb_model = pipeline.named_steps['gradientboost']\n",
    "\n",
    "# Get feature importances\n",
    "importances = gb_model.feature_importances_\n",
    "\n",
    "# Get feature names after preprocessing using .get_feature_names_out()\n",
    "try:\n",
    "    feature_names_out = pipeline.named_steps['preprocessor'].get_feature_names_out()\n",
    "except AttributeError:\n",
    "    print(\"Warning: .get_feature_names_out() not found for preprocessor. Falling back to manual inference.\")\n",
    "    transformed_numerical_features = numerical_cols\n",
    "    ohe = pipeline.named_steps['preprocessor'].named_transformers_['cat'].named_steps['onehot']\n",
    "    ohe_feature_names = ohe.get_feature_names_out(categorical_cols)\n",
    "    feature_names_out = transformed_numerical_features + list(ohe_feature_names)\n",
    "\n",
    "\n",
    "# Create a DataFrame for better visualization\n",
    "feature_importance_df_gb = pd.DataFrame({\n",
    "    'Feature': feature_names_out,\n",
    "    'Importance': importances\n",
    "})\n",
    "\n",
    "# Sort by importance\n",
    "feature_importance_df_gb = feature_importance_df_gb.sort_values(by='Importance', ascending=False)\n",
    "\n",
    "# --- 9. Display and Plot Feature Importances ---\n",
    "print(\"\\nTop 20 Feature Importances (Gradient Boosting Model):\")\n",
    "print(feature_importance_df_gb.head(20))\n",
    "\n",
    "plt.figure(figsize=(12, 8))\n",
    "sns.barplot(x='Importance', y='Feature', data=feature_importance_df_gb.head(20))\n",
    "plt.title('Top 20 Feature Importances (Gradient Boosting)')\n",
    "plt.xlabel('Importance')\n",
    "plt.ylabel('Feature Name')\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n",
    "# --- Optional: Sum importance for original categorical features ---\n",
    "print(\"\\n--- Summed Importance for Original Categorical Features ---\")\n",
    "for cat_col in categorical_cols:\n",
    "    relevant_importances = feature_importance_df_gb[\n",
    "        feature_importance_df_gb['Feature'].str.startswith(f'cat__{cat_col}_')\n",
    "    ]\n",
    "    if not relevant_importances.empty:\n",
    "        print(f\"Total Importance for '{cat_col}': {relevant_importances['Importance'].sum():.4f}\")\n",
    "    else:\n",
    "        print(f\"No one-hot encoded features found for '{cat_col}'.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "9ccbda0b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "47"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "47"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7f13dcd8",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
